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Gene expression can be controlled at the level of mRNA stability, and prior studies 
from our laboratory have explained how Programmed -1 Ribosomal Frameshifting (-1 
PRF) fits within this paradigm. Computational analyses suggest that 10-15% of 
eukaryotic mRNAs contain at least one potential -1 PRF signal.  The overwhelming 
majority of predicted “genomic” -1 PRF events are predicted to direct translating 
ribosomes to premature termination codons. We have demonstrated that these can 
function as mRNA destabilizing elements through the Nonsense-Mediated mRNA 
Decay (NMD) pathway. In published work we have explored the biological 
significance of the connection between -1 PRF and NMD on telomere maintenance in 
yeast. More recently we extended this line of inquiry to human cells, demonstrating 
that a sequence element in the mRNA encoding Ccr5p harbors a -1 PRF signal which 
functions as an mRNA destabilizing element through NMD. In the current work we 
are exploring the link between global changes in -1 PRF rates and human health using 
yeast and human cell-based models of two diseases, X-linked Dyskeratosis Congenita 
  
(X-DC) and Spinocerebellar ataxia 26 family (SCA26) as models.  Preliminary 
findings suggest these genetically inherited defects result in translational fidelity 
defects (i.e. changes in rates of -1 PRF, +1 PRF, and stop codon recognition), with 
attendant effects on mRNA abundance, gene expression and telomere maintenance. 
These studies establish a paradigm for understanding the linkage between 
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Gene regulation is achieved by myriad cellular processes. In the ‘Central Dogma’ of 
molecular biology mRNA is centrally placed in the flow of information in biological 
systems and the regulation of mRNA abundance is extremely important. The rates of 
mRNA transcription and degradation, silencing and storage of mRNA are the 
parameters that affect mRNA abundance. Post-transcriptional control mechanisms of 
gene regulation have the strongest effects on mRNA abundance and hence on protein 
levels. These mechanisms are mainly attributed to cis-acting elements in the 5’ and 3’ 
untranslated regions of mRNAs and to the trans-acting factors that they interact with. 
The role of protein coding regions in translational control remains largely unexplored. 
Cis-acting elements in protein coding regions are generically classified as “recoding” 
elements. Recoding phenomena denote exemptions to the rules of the genetic code. 
These include, but are not limited to -1 and +1 Programmed Ribosomal 
Frameshifting, termination suppression, stop-start elements and incorporation of 
selenocysteine or pyrolysine. These non-canonical mechanisms were first described 
in viruses and later identified in prokaryotic and eukaryotic genomes (1). Viruses use 
translational recoding mechanisms for their proteomic expansion, while most 
recoding events in eukaryotes  serve to fine-tune gene expression during 
posttranscriptional regulation (2)(3).  
Speed and accuracy of translation are important attributes that help maintain cellular 




polypeptides, can result in protein misfolding, aggregation and disruption of cellular 
fitness. Dysfunctional translational machinery has deleterious effects on global gene 
expression and such defects are associated with a growing number of human diseases 
collectively known as ‘ribosomopathies’. Although each ribosomopathy is associated 
with specific pathologies, all are generally first typified by the appearance of anemias 
and, later in life, by cancers (5). The heart of this thesis is to explore how defects in 
the interplay between mRNAs and ribosomes affect gene expression and contribute to 
disease pathogenesis. 
The Translation cycle 
 
The abundance of the mRNA is tightly regulated from transcription to degradation. 
Eukaryotic mRNA is synthesized by RNA polymerase II as a primary transcript from 
the transcriptional unit. The transcriptional unit is a region on the genome that 
contains appropriate signals for transcriptional initiation and termination. The cis-
elements that flank the transcriptional unit and the proteins that interact with them 
regulate the levels of the nascent mRNA. Maturation of the nascent mRNA involves 
5’ end capping methylation, pre-mRNA splicing, and poly (A) addition to the 3’ end 
(6). Once the mature fully processed mRNA is synthesized in the nucleus it is 
transported to cytoplasm and translated by the ribosome. The actively translating 
ribosome co-ordinates the intricately series of individual activities required to 








Translation initiation in eukaryotes is the multistep process that first recruits the 
ribosomal 40S subunit (small subunit or SSU) to the mRNA, translocates it to the 
appropriate initiation codon, and then recruits the 60S subunit (large subunit, or 
LSU). In cap-dependent translation, translation initiation begins with two parallel 
processes: 1) recruitment of initiator tRNA to the 40S subunit in complex with 
eukaryotic initiation factors (eIF) 1, 1A, 5 and 5 to make the 43S pre-initiation 
complex, and 2) recruitment of the eIF4-complex of proteins to 5’ (7mGpppN) cap of 
the mRNA (7). The cap binding proteins eIF4E and eIF4G in turn can bind to the 
poly (A) binding protein (PABP) associated with the 3’ untranslated region (UTR) to 
“circularize” the mRNA, stabilizing it against exonucleolytic attack. Once 
circularized, the 43S pre-initiation complex is recruited to the mRNA, where it 
subsequently scans in the 5’ to 3’ direction in the  5’ UTR until it recognizes an AUG 
start codon in an appropriate context (8). After the recognition of initiation codon and 
48S complex formation (43S complex and eIF3, eIF1, eIF1A), eIF5 and eIF5B 
promote the hydrolysis of eIF2-bound GTP. Clearance of these factor enables60S 






Figure 1. Model of canonical eukaryotic translation initiation pathway. 
Translation initiation in eukaryotes begins by the recruitment of the 43S pre-initiation 
complex on the mRNA through the cap binding complex. Once recruited the 43S pre-
initiation complex scans for the initiation codon to form the 48S initiation complex. Post 
recognition of the initiation codon the structural rearrangements in the 48S initiation complex 
promote GTP hydrolysis of eIF5 and eIF5B, recruiting the 60S subunit to form the 






 Once the two subunits join, base pairing interactions between the initiator tRNA and 
the AUG start codon in the ribosomal P-site function to define translational reading 
frame. In canonical translation, reading frame must be maintained throughout the 
process. During each translation elongation cycle, an aminoacyl tRNA is delivered to 
the A-site by in complex with eEF1A and GTP – this is called the Ternary Complex 
(TC). Properly charged aa-tRNAs delivered by the TC and the complementary base 
pairing between anticodon on aminoacyl tRNA and mRNA codon results in the 
acceptance of the tRNA, a process called accommodation(10),(11). Accommodation 
of the aa-tRNA prompts a conformational change in ribosome that triggers GTP 
hydrolysis by eEF1A, releasing eEF1A. During the elongation process, this also 
results in release of deacylated  tRNA from the E-site (Figures 2 and 3)(12)(13)(14). 
 
Figure 2 The positions of the tRNAs during the elongation cycle: the Hybrid States 
model. 
The relative positions of the tRNAs during the ‘classical’ (unrotated) and the ‘hybrid’ 
(rotated) states during translational elongation. The figure is modified from (15). 
 
After accommodation, the 3’ end of the aa-tRNA is positioned directly at the 




nascent peptide from the incoming aminoacyl-tRNA in a trans-esterification reaction 
called  peptidyltransfer (16). Post peptidyltransfer the tRNAs that were previously in 
the ‘classical’ (unrotated) state of P/P and A/A adopt the ‘hybrid’ (rotated) P/E and 
A/P conformation(17)(18). The hybrid state permits the binding of the ternary 
complex mimic eEF2 and GTP. Binding of eEF2-GTP drives the small subunit to 
rotate back to the unrotated (classical) state, moving the ribosome along the mRNA in 
the 3’ direction by three nucleotides in a process called translocation. Subsequently, 
GTP hydrolysis enables eEF2 dissociation, completing the translation elongation 
cycle (Figure 3). (19)(20).  
 
Figure 3 Overview of the eukaryotic translational elongation. 
 Eukaryotic translation elongation is a multi-step process, where the ribosome is either in the 
‘classical’ (unrotated) and the ‘hybrid’ (rotated) state. Elongation factors eEF1A and eEF2 










Three codons, UAA, UAG and UGA do not code for any amino acid. They do not 
have any cognate tRNAs(22), and are called “stop” or “nonsense” codons. When 
these codons are enter the A-site during elongation protein factors called release 
factors (RFs) bind to the ribosome. In eukaryotes, a single release factor eRF1 
(eukaryotic release factor 1) decodes all the three stop codons in association with 
eRF3 (a G-protein) and GTP. The eRF1:eRF3:GTP complex is a molecular mimic of 
the aminoacyl tRNA TC(23). The binding of this complex promotes a hydrolysis 
reaction resulting in release of the peptide from ribosome-associated tRNA (24)(14).   
 
 
Figure 4. The model of eukaryotic translation termination 
 Recognition of the stop codon recruits the eRF1:eRF3:GTP complex to the ribosomal A-site. 
eRF3 is a G-protein. This is followed by the binding of ABCE-ATP to the release factor 
complex. Subsequent GTP and ATP hydrolysis results in release of the ribosomal subunits 





Post peptide release the 80S ribosomal subunits along with the deactylated tRNA (at 
the P-site) and the eRF1 (at the A-site) are still bound to the mRNA (Figure 4). 
Recent data suggests that the protein ABCE1 (an ATPase) promotes ribosomal 
subunits release and subsequent recycling. According to another model the release of 
ribosomal subunits and recycling is achieved via eIF3 (eukaryotic initiation factor 3) 




In canonical translation, the ribosome initiates at a ‘start’ codon, maintains reading 
frame during elongation, and terminates at a canonical ‘stop’ codon. The directed or 
programmed alteration to this canonical process is usually referred to as ‘translational 
recoding’. These recoding events are mRNA specific and the mRNA sequences that 
direct them are known as ‘recoding signals’. While undirected recoding events are 
very rare, the presence of specific cis-acting elements on mRNAs can increase their 
frequencies by up to 2 – 3 orders of magnitude (26).  The most common translational 
recoding events involve either repositioning of the ribosome on an mRNA 
(programmed ribosomal frameshifting, or PRF), or decoding of stop codons with a 
tRNA (termination suppression). Common variations within these two general 
categories include directing the ribosome to slip by one base in the 5’ direction (+1 
PRF), one base in the 3’ direction (-1 PRF), or utilizing various suppressor tRNAs at 





Programed -1 Ribosomal Frameshifting 
 
Programmed -1 frameshifting (-1 PRF) was first described in retroviruses(27)(28). In 
viruses -1 PRF uses a single mRNA transcript to encode two peptides and maintain 
them at a specific ratio.  The majority of the translated product consists of the shorter, 
unshifted protein.  A -1 PRF event causes the ribosome to bypass the 0-frame 
termination codon, resulting in a C-terminally extended fusion protein. -1 PRF has 
been identified in plus stranded RNA viruses, dsRNA viruses, and retroviruses 
(29)(30) (Figure 5).  The L-A virus of yeast uses -1 PRF to regulate its ratio of 
structural capsid protein (gag) and gag-pol fusion protein to incorporate the RNA-
dependent RNA polymerase (pol) into the viral particle (31). Changing the rate of -1 
PRF negatively impacts the process of viral particle assembly by altering the gag/gag-




      
Figure 5.  Viral -1 PRF: Organization and regulation of gene expression 
The figure shows a schematic of -1 PRF signals in L-A, HIV-1 and SARS genomes. The 
overlap regions highlighted by the rectangles harbors the -1 PRF signals. These sequences on 
the mRNA stochastically shift reading frame of the elongating ribosome and translate a 
fusion protein. Thus we have a scenario where the virus is able to coopt the host’s 
translational machinery to get a specific ratio of two protein products from a single transcript.  
 
A typical -1 PRF signal as shown in (Figure 6). It consists of following components: 
a ‘slippery’ heptameric sequence of seven nucleotides where the actual slippage of A- 
and P- site tRNAs takes place; a short spacer region of zero to 14 nucleotides and a 
downstream stimulatory mRNA secondary structure (33). The IUPAC notation of the 
slippery heptameric sequence is denoted by N NNW WWH (spaces denote reading 
frame); where N is any three identical bases, W is any three identical weak bases and 




elongating ribosome pauses due to the mechanical barrier presented by the 
downstream mRNA structure. At this point the peptidyl and aminoacyl-tRNAs are 
placed at the heptameric slippery site. While the ribosome resolves the downstream 
secondary structure the tRNAs break codon:anti-codon interactions and re-basepair 
one nucleotide upstream, causing the translational reading frame to shift one 
nucleotide in the 5’ direction (28). 
Additionally the ‘integrated model of -1 PRF’ hypothesizes that the tRNA slippage 
occurs post-delivery of the aa-tRNA and before peptidyltransfer and 
translocation(33). According to this model the downstream RNA secondary structure 
obstructs the movement of the ribosome resulting in the tension at the mRNA entry 
tunnel(34). This tension can be relieved by breaking codon:anti-codon base pairing 
and re-base pairing one nucleotide backwards(35). According to another model, the -
1 PRF event occurs due to incomplete translocation. The downstream element 
impedes the ribosome movement resulting in a 2 nucleotide translocation (instead of 






Figure 6. Structure and mechanism of -1 PRF. 
The elements of a -1 PRF signal include a slippery heptamer of the form NNNWWWH 
(IUPAC notation), a spacer and a downstream mRNA secondary structure which is usually an 
H-type pseudoknot. A frameshift event occurs during the ribosomal pause when a translating 
ribosome encounters downstream secondary structure, usually a pseudoknot. This creates 
tension along the spacer which is relieved by a shift of one base, where by the P- and A- site 
codons at the slippery site repair in the -1 frame and translation continues. The figure is 
modified from (37). 
 
 
A separate model posits that the tRNAs in the E- and P-sites are located over the 
NNW WWH nucleotides of the heptameric slippery site are forced to move one 
nucleotide backwards due to the downstream stimulatory structure, such that the 




occurs during the subsequent translocation post peptidyltransfer. All the above 
discussed models are supported by empirical data, hence the mechanism of -1 PRF 
can be described as a series of ‘kinetic partitioning’ events occurring during 
elongation(38)(39). (Figure 7). 
 
 
Figure 7. Kinetic partitioning of mechanisms of -1 PRF. 
 Two elongation cycles are diagrammed showing the on-product 0-frame translation and three 
separate pathways which result in the ribosome reading in the -1 frame.  Thus the aminoacyl-
tRNA mechanically wedges into the A-site during the first translocation event (Pathway I); 
tension of the mRNA caused by the mRNA secondary structure is relieved by slippage during 
the second accommodation event (Pathway II); or the second elongation cycle is frustrated by 




Historically most molecular mechanisms are first discovered in viruses and later 




PRF is used to regulate cellular mRNAs’. Thus the Dinman laboratory queried the 
prevalence of -1 PRF signals in eukaryotic genomes and found suitable frameshift 
sites at much higher frequenceies than random (40). The publically available 
databases of +1 and -1 PRF signals are incomplete and do not provide a user friendly 
interface to search for recoding signals of one kind (41)(42)(43). The Programmed 
Ribosomal Frameshifting database (PRFdb) serves this need of providing a user 
friendly interface to search predicted -1 PRF signals over 20 eukaryotic genomes(44). 
The PRFdb computational pipeline is shown in Figure 8.  
 
Figure 8. Pipeline for predicting and validating genomic -1 PRF signals. 
 Mature mRNA sequences to be analyzed are imported from the available databases. These 
sequences are filtered by RNAmotif and structure prediction algorithms for correctly placed 
slippery sites and downstream stimulatory secondary structure. The predicted sequences are 
randomized and refolded to calculate randomized MFEs (minimum free energies) and Z 
scores and stored in the database. Interesting candidates that are both biologically and 
statistically significant are taken to bench for validation and characterization. 
 
A general observation from analysis of the PRFdB is that, unlike viral PRF signals, 
there are very few coding regions in the   -1 frame immediately following a PRF 
signal.  Instead, -1 frame termination codons were found closely downstream from 




shift reading frame in response to these cis-acting PRF signals would terminate 
translation prematurely.  As a result, messages containing PRF signals would be 
regulated similarly to messages containing a premature termination codon (PTC) 
(45).   
 
 
Programed + 1 Ribosomal Frameshifting 
 
Examples of +1 PRF signals have been described in viruses (46)(47), E. coli (48), 
yeast (49) (50) and mammalian cells (51). In a +1 PRF event the slippage of the 
tRNAs also occurs at the heptameric slippery site. The requirement of a downstream 
RNA secondary structure is optional. A well-studied example of +1 PRF is the yeast 
Ty1 retrotransposon of yeast. The 0-frame translation results in synthesis of the gag 
structural protein and a +1 PRF event results in production of a C-terminally extended 
gag-pol fusion protein (52) (53). The frameshift occurs at the heptameric sequence 
‘CCU AGG C’. The AGG codon is called a ‘hungry codon’ (its cognate tRNA is in 
low abundance in the cell), which causes the ribosome to pause. The ribosomal pause 
causes the P-site tRNA to slip one nucleotide in the 3’ direction, such that the next 
codon is ‘GGC’. There is no RNA secondary structure downstream of the slippery 
sequence. The yeast gene EST3, encoding  a component of the telomerase 
holoenzyme complex, harbors a +1 PRF signal between ORF1 and ORF2 (54). The 
+1 PRF event occurs over the slippery site of ‘CUU AGU U’ (Figure 9). This allows 
the translation of full-length Est3p (55). 
A +1 PRF signal is also found in the yeast gene of OAZ1, encoding ornithine 




decarboxylase. A +1 PRF event, which is induced by high levels of polyamines, 
results in synthesis of full-length antizyme (56)(57). OAZ1 +1 PRF requires the 
heptameric slippery site ‘UCC UGA U’ and a downstream pseudoknot that induces a 




Figure 9. Programed +1 ribosomal frameshift signal in yeast EST3 gene. 
The +1 PRF signal in the EST3 gene is conserved in many yeast species. The overlap 
sequence between ORF1 and ORF2 harbors the slippery sequence ‘CUU AGU UGA’. The P-
site tRNA slips one nucleotide in the 3’ direction. This results in bypass of the 0-frame 




Accurate stop codon recognition is an important aspect of translational fidelity. 
Nonsense suppression (also called stop codon readthrough) refers to the rate at which 




UGA codon, as a mechanism of nonsense suppression is well studied. This requires a 
selenocysteine incorporation signals (SECIS)  3’ of the UGA (59). The SECIS is 
recognized by a specialized elongation factor SelB that delivers the tRNAsec to the A-
site. In eukaryotes the SECIS is located in the 3’ UTR and requires an adaptor protein 
SBP2 (60)(61) (Figure 10.). 
 
Figure 10. Mechanism of Selenocysteine incorporation. 
The diagram shows the general mechanism of selenocysteine incorporation at UGA in both 
prokaryotes and eukaryotes. Selenocysteine incorporation in prokaryotes requires specialized 
elongation factor SelB and selenocysteine incorporation signals (SECIS) immediately after 
the stop codon. In eukaryotes the SECIS is located in the 3’ UTR and the selenocysteine 
incorporation requires an additional accessory protein SBP2. This figure is from (55). 
 
Programmed stop codon readthrough is also employed by many RNA viruses as a 
strategy for proteomic expansion. In the Murine leukemia virus (MuLV), it is 
achieved through a ribosomal pause induced by a strong pseudoknot (62)(63). The 
ribosomal pause enables the reverse transcriptase to interact with the eRF1 that 
enhances the efficiency of stop codon readthrough via depletion of the release factor 
(64). Recent published work has shown that the expression a cellular gene,  the anti-
angiogenic factor VEGF-Ax is regulated through programed translational (stop 





Nonsense Mediated (mRNA) Decay Pathway 
 
The NMD pathway evolved to maintain transcriptome fidelity primarily by disposing 
of mRNAs with premature termination codons (PTC) (66)(67)(68)(69). Such 
transcripts can arise defects in a gene sequence itself, aberrant transcription and 
through splicing errors. Alternatively spliced and selenoprotein encoding mRNAs are 
also substrates of NMD (70)(71)(72). Recent work also suggests selective 
degradation of certain mRNAs is also dependent on the nature of the 3’ UTR 
(73)(74)(75).  
 
General model of NMD in Saccharomyces cerevisiae 
 
The NMD surveillance complex in yeast requires the three Upf proteins Upf1-3 (76). 
The Upf1:Upf2:Upf3 complex works by interacting with the release factors upon 
decoding of a stop codon that is not located close to the polyA tail. In  this context, , 
the association of release factors occurs in the absence of Pab1, enhancing 
recruitment of the Upf1 to the eRF1-eRF3 complex (77). Upf1 activation happens 
after its association with Upf2 and Upf3. The Upf1:Upf2:Upf3 complex binds the 
ribosome through interactions between Upf1 and rpS26 (78). Activation of Upf1 
causes release and degradation of the peptide and subsequent dissociation of eRF3 
from the termination complex (Figure 11). The large subunit dissociates from the 
mRNA while the small subunit is still bound. Upf1 also recruits the decapping 




(79)(80). Transcripts with 3’UTRs, that sequester the Pab1 from the bonafide stop 
codon, are good substrates for NMD (75). 
 
Figure 11. General model of NMD in yeast. 
NMD is triggered by the recognition of the premature termination codon by the termination 
complex in yeast and binding of Upf1. In context of PTC the absence of Pab1p in the vicinity 
promotes the association of Upf1 with the termination complex. Subsequent activation of 
Upf1 causes peptide release, ribosomal subunit dissociation and activation of downstream 








General model of NMD in Mammalian cells. 
 
The exon junction complex dependent (EJC) dependent model of NMD is well 
studied in mammals. Post splicing the EJCs remain bound to the mRNA 20-24 
nucleotides upstream of the exon-exon junctions. The NMD protein Upf2 associates 
with the EJCs. Since the actual stop codons are located in the final exon, the presence 
of an EJC 5’ of the stop codon is unusual. Termination complex assembly at such a 
stop codon, where the EJC is located > 50-55 nucleotides upstream of an EJC, 
triggers NMD through UPF2. The UPF1 recruits UPF2 which in turn recruits UPF1 to 
the termination complex at the PTC (81). This is followed by the association of 
SMG1 with UPF1 (82)(83). The UPF1, SMG1 along with the release factors form the 
SURF complex (84). Phosphorylation of UPF1 by SMG1 results in the recruitment of 
SMG6 and SMG5-7 complex. SMG6 performs the endonucleolytic cleavage between 
the PTC and the EJC and SMG5-7 complex recruits the decapping and 













Figure 12. General model of EJC dependent NMD in mammalian cells. 
The premature termination codon is recognized when the termination complex 3’ of the EJC. 
The UPF2 protein associated with the EJC recruits the SURF complex. This triggers NMD by 
recruiting decapping and polydeadenylating complexes at the 5’ and 3’ end of the mRNA. 
The figure is from (87). 
 
Alternative models of NMD   
 
Other less characterized models of the surveillance pathway have been discovered in other 
eukaryotes. The faux 3’ UTR model of NMD has been studied in drosophila and yeast (88) 
(74). In normal termination the recruitment of the termination complex happens in the 
vicinity of Pabp1 followed by subsequent release and recycling of ribosomal subunits (89). 
According to the faux 3’ UTR model the interaction between the ribosome and mRNPs in the 
3’UTR is necessary for the appropriate termination and normal rates of mRNA decay (Figure 
13). Absence of these mRNPs in the vicinity of the stop codon triggers NMD. Studies have 
also shown that introns located upstream of the PTC can also enhance mRNA decay, 




alternative branch of NMD that relies on the less characterized factor of UPF3a has been 
studied in T cells (91). 
 
Figure 13. Faux 3’UTR model of NMD. 
The translation termination at the PTC is inefficient due to the lack of interaction between 
termination complex with the Pabp1. This activates NMD by recruitment of UPFs at the 
termination complex thereby enhancing rapid mRNA decay. The figure is from (88). 
 
Most mammalian genes have introns and splicing defects can generate aberrant PTC-
containing transcripts. These deleterious mRNAs are largely degraded via NMD. In 
yeast, microarray data suggests that approximately 12% of the genes are regulated 
through NMD (92). Thus NMD is a major post-transcriptional surveillance pathway 
and defects in NMD have severe implications on global gene expression. The deletion 
of NMD factors UPF1 and UPF2 causes embryonic lethality in drosophila, mice and 
zebrafish (93)(94). Recent studies have shown that, this surveillance pathway serves 
as a moderator in the manifestation of hereditary and acquired genetic diseases 









Figure 14. The distribution of length of -1 PRF signal encoded peptides in Homo 
sapiens. 
The graph shows the length of peptide encoded post -1 PRF event on X-axis and the number 
extension on Y-axis for all predicted -1 PRF signals in the humans. 
 
 
In viruses, -1 frameshift events typically cause elongating ribosomes to bypass the 0-
frame stop codon enabling the synthesis of C-terminally extended fusion proteins. In 
contrast the vast majority of cellular -1 frameshift event redirect elongating ribosomes 
to premature termination codons. This is demonstrated in Figure 14, which shows the 
distribution of peptide lengths encoded after -1 PRF events for all predicted -1 
frameshift signals in the human genome: only 0.07% of candidate -1 PRF containing 
sequences extend more than 30 codons beyond the frameshift event (37). This led to 
the hypothesis that ‘-1 PRF signals function as mRNA destabilizing element via the 
NMD pathway’. When an elongating ribosome is directed to a premature termination 
codon after a -1 frameshift event, it recruits the components of NMD pathway 




tested using example of -1 PRF signal in yeast L-A virus (96) and later validated 
using the -1 PRF signal in the EST2 mRNA (97). The yeast EST2 gene encodes the 
reverse transcriptase subunit of the telomerase complex (98). The open reading 
frames of EST2 has five functional -1 PRF signals. It was shown that the full length 
native EST2 mRNA is a substrate of NMD due to -1 PRF and ablation of all five -1 
PRF signals resulted in stabilization of EST2 mRNA (97). Similarly the -1 PRF signal 
containing human CCR5 mRNA was stabilized upon ablation of -1 PRF (99). Thus, 
NMD is downstream to -1 PRF. 
 
 
Figure 15.  Model of -1 PRF dependence on NMD. 
For genomic frameshift signals an elongating ribosome is directed to a -1 frame premature 
termination codon after as frameshift event. The recognition of the PTC by the ribosome 






Ribosome Biogenesis and Ribosomopathies. 
 
Ribosome biogenesis is a complex multistep process involving over 200 accessory 
proteins and transacting factors (100)(101). In yeast the ribosomal RNA (rRNA) is 
transcribed by RNA polymerase I, except 5S rRNA which is transcribed by RNA 
polymerase III. The pre-rRNA undergoes exonucleolytic and endonucleolytic 
cleavages followed by base modifications to form mature 18S, 25S and 5.8S rRNA 
(102). The most common base modifications include pseudouridylation and 
methylation (103). Pseudouridylation is the largest single base modification in rRNA. 
The ribosomal proteins are transported to the nucleolus, where they are processed and 
assembled with the rRNA to form 43S and 66S preribosomal particles that are 
transported to the cytoplasm (104). These preribosomal subunit are transported with 
some non-ribosomal proteins that prevent the premature association of the ribosomal 
subunits.  
Ribosomopathies are a class of congenital diseases caused by structural and 
functional defects of the ribosomal components. Ribosomopathies are rare and are 
characterized by hypo-proliferative phenotype characterized by bone marrow failure, 
anemias, dystosis and recently have been associated with the tumor suppressor 
protein p53 (105). Table. 1 shows the list of currently accepted ribosomopathies and 
their causative gene defects. In general ribosome dysfunction results in defects in 
protein synthesis and the ensuing disease pathogenesis. In chapter 3, we use X-DC as 
a model for ribosomopathies to investigate the effects of translational fidelity defects 









proteins (esp. S19, 
































abnormalities (e.g. skin 
pigmentation and nail 
changes) 
Pulmonary fibrosis 




RMRP Short stature 
Bone deformities 




TCOF1 Craniofacial abnormalities Symptomatic 
Bowen-Conradi 
syndrome 








Table 1. Clinical characteristics of different ribosomopathies. 
This table is adapted from (105). 
Scope of work and Thesis Summary 
 
The heart of the work described in this thesis is to understand how defects in the 
interplay between mRNAs and ribosomes can affect gene expression and thus 
contribute to disease pathogenesis. Emerging research shows that exceptions to the 
rules of translation play critical roles in regulating gene expression.  Structured 
segments of RNA can ‘program’ ribosome to slip on mRNAs to either produce 




Frameshifting, having recently been identified as molecular mechanism for regulating 
gene expression in eukaryotes, has emerged as the paradigm in this line of research 
has. Published work has increased our understanding of the molecular and 
biophysical mechanisms underlying -1 PRF and computational analysis predicts that 
approximately 10% of the genes in both yeast and humans are regulated via this 
mechanism (44). The observations that global dysregulation of -1 PRF has deleterious 
effects on gene expression leads us to hypothesize that ‘-1 PRF plays an important 
role in regulating cellular gene expression’. The most important aspect of this thesis 
work is to explore the biological and biomedical significance of -1 PRF.  There is 
growing evidence that defects in the structure and function of the ribosome and its 
trans-acting factors which compromise translational fidelity, including altered rates of 
-1 PRF, plays an important role in class of diseases called ribosomopathies. Recent 
observations have shown that mutations associated with the ribosomopathy X-linked 
Dyskerotosis Congenita (X-DC) and Spinocerebellar ataxia type 26 (SCA26) promote 
increased rates of -1 PRF along with the other defects in translational fidelity 
(106)(107). This work uses this preliminary data as a foundation to characterize how 
defects in the aspects of translation contribute to disease pathogenesis. 
 The work presented in the following chapter explores the role of -1 PRF in the yeast 
telomere maintenance and cell cycle control. Preliminary data also suggests that this 
may be also applicable to human cells. Regulation of telomere length is biologically 
important because of its association with ageing and cancer. In Chapter 3, we discuss 
X-DC and SCA26 as models to understand how inherited defects in translational 




PRF signals in additional human genes that are associated with other human disease. 
These studies establish a paradigm for understanding the linkage between 








Telomere maintenance is globally controlled by programmed 




Programmed ribosomal frameshift (PRF) signals are cis-acting elements located 
inside of open reading frames in mRNAs that are able to stochastically redirect 
translating ribosomes to shift into alternative reading frames. In the typical viral 
context, these elements allow the translational apparatus to bypass a 0-frame encoded 
in-frame stop codon and continue synthesis of a C-terminally extended fusion protein. 
The use of programmed -1 ribosomal frameshifting (-1 PRF) by a wide variety of 
RNA viruses has enabled definition of some broad rules for at least one class of these 
elements (2).  A typical -1 PRF promoting mRNA sequence motif contains three 
elements: a heptameric “slippery site” where the translational shift in reading frame 
actually takes place; a short spacer sequence of usually less than 12 nucleotides; and a 
downstream stimulatory structure (usually an mRNA pseudoknot). In eukaryotic 
RNA viruses, the slippery site has the heptameric motif N NNW WWH, where the 
incoming reading frame is indicated (33). Current models posit that aminoacyl- (aa-) 
and peptidyl-tRNAs are positioned on this sequence while the ribosome pauses at the 
downstream secondary structure, which is thought to provide an energetic barrier to 




nature of the slippery sequence enables re-pairing of the non-wobble bases of both the 
aa- and peptidyl-tRNAs with the -1 frame codons. mRNA pseudoknots are the most 
common stimulatory structures but stem-loops and other structures are also capable of 
stimulating -1 PRF (110)(111) .  
 
There are a growing number of examples of functional PRF signals in expressed 
eukaryotic gene (112)(54)(113)(114)(115)(116)(45).  The existence of these PRF 
signals in a wide variety of viral and prokaryotic genomes suggests an ancient and 
possibly universal mechanism for controlling the expression of actively translated 
mRNAs. The past few years have seen the publication of several reports describing in 
silico identification of “recoding signals” using a wide variety of computational 
approaches(40)(117)(118)(119)(120). While many different bioinformatics 
methodologies have been used, these tend to fall into two general and complementary 
strategies.  The first, based on the observation that viral frameshifting events direct 
ribosomes into new ORFs, is to first find out-of-frame ORFs followed by the 
identification of sequences that may function as PRF signals. The strength of this 
approach is that it can identify new classes of cis-acting signals capable of directing 
efficient PRF; its weakness is that it cannot identify new functional outcomes of 
frameshifting. The second strategy involves searching for mRNA motifs known to 
promote efficient PRF. While this approach cannot identify new classes of frameshift 
signals, it can enable an expansion of our understanding of functional uses for PRF. 
Using this strategy and a package of bioinformatics and statistical tools, we 




contain high confidence -1 PRF signals(45)(40)(44).  Interestingly, like many cis-
acting elements, -1 PRF signals appear to rapidly evolve, and wet lab studies 
demonstrated that 9 (out of 9 selected) high confidence putative -1 PRF signals from 
a variety of S. cerevisiae genes promoted efficient recoding in vivo (97).  A 
searchable database of predicted -1 PRF signals in these genomes is available in the 
Predicted Ribosomal Frameshift Database (PRFdb) at http://prfdb.umd.edu/. 
 
One key finding of our research is that the outcome and function of -1 PRF differs 
significantly between viruses and eukaryotic genomic frameshifting.  While viral -1 
PRF events direct ribosomes into new ORFs, resulting in synthesis of C-terminally 
extended proteins, the vast  majority of -1 PRF events on eukaryotic cellular mRNAs 
are predicted to direct elongating ribosomes to premature termination signals, 
suggesting that -1 PRF is used to control mRNA abundance and stability through the 
nonsense-mediated mRNA decay (NMD) pathway. This hypothesis was supported by 
the demonstration that a well characterized viral -1 PRF signal can act as a cis-acting, 
NMD-dependent mRNA destabilizing element (96).  A more recent study revealed 
that functional -1 PRF signals derived from naturally occurring yeast mRNAs can 
promote rapid degradation of a reporter mRNA by -1 PRF through NMD and, to a 
lesser extent, the no-go decay (NGD) pathway (97).  That work began to explore the 
biological significance of -1 PRF by using the yeast EST2 mRNA, which encodes the 
catalytic subunit of telomerase.  There, we showed that the EST2 mRNA is 




its stabilization, and that global increases or decreases in -1 PRF resulted in decreased 
or increased steady-state abundance EST2 mRNA respectively (97).  
 
During the course of that study, additional putative −1 PRF signals were 
computationally identified in the EST2 mRNA and in the mRNAs encoding other 
components and regulators of telomerase: Est1p, Stn1p, and Cdc13p.  Importantly, all 
of these mRNAs are stabilized in NMD− cells (121), and we speculated that yeast 
cells may use −1 PRF to limit the expression of these proteins in order to maintain the 
correct stoichiometric balance among telomere associated components. Here, we have 
empirically characterized the computationally predicted -1 PRF signals in these 
mRNAs, demonstrating that each contains at least one operational -1 PRF signal.  
That the same underlying molecular mechanism is operational is suggested by 
experiments showing that mutated slippery sites ablate -1 PRF, and by the 
demonstration that all are responsive to mutants and drugs that were previously 
shown to alter rates of -1 PRF as directed by a virus derived signal.  In general, the 
ability to function as mRNA destabilizing elements correlated with the extent to 
which any particular element promoted -1 PRF, and in these cases, ablation of NMD 
resulted in partial stabilization of a reporter mRNA. Importantly, altering rates of 
EST2 mRNA -1 PRF, either by ablation of EST2 slippery sites, through the activity 
of extragenic mutants, or by the use of -1 PRF altering drugs mimicked the effects on 
NMD ablation of yeast telomere length.  These findings suggest that -1 PRF is 
utilized to control the abundance of telomerase components, and thus telomere length 




messages encoding proteins required for telomere maintenance. This suggests that -1 
PRF may also play important role in human telomere maintenance and ageing. 
Results 
 
The mRNAs encoding at least 4 proteins involved in yeast telomere maintenance 
contain operational -1 PRF signals.   
A search for -1 PRF signals in the yeast EST2 mRNA revealed 10 slippery sites in the 
correct reading frames, and further examination of the computationally predicted 
structures and statistical analyses suggested that 5 of these had the potential to encode 
operational -1 PRF signals (Table 2 and Figure 16).  Note that, while the signal 
beginning at position 72 appeared to lack significant mRNA structure, the presence of 
a “double slippery-site” A AAU UUA AAA made it an attractive candidate 
nonetheless.  Similarly, searches for -1 PRF signals in the mRNAs encoding other 
proteins involved in telomere maintenance revealed three candidates in EST1, two in 
STN1 and one in CDC13.  Synthetic oligonucleotides containing these sequences 
were used to clone the predicted -1 PRF signals into standard yeast high copy dual-
luciferase reporter plasmids (122).  Note that in order for frameshifted ribosomes to 
bypass -1 frame termination codons present in the native sequences, either 1 base was 
deleted from, or 2 bases were added to the spacer regions immediately 3’ of the 
slippery sites, thus directing shifted ribosomes back into the original reading frame 






Figure 16. Predicted -1 PRF signals in ORFs involved in yeast telomere maintenance. 
Sequences of potential -1 PRF signals in EST1, EST2, STN1 and CDC13 ORFs assayed in 
this study. The number represents the tandem slippery site beginning within the ORF. The 





While these modifications may change actual rates of -1 PRF, the resulting plasmids 
nonetheless remain useful for determining whether or not the sequences in question 
are fundamentally capable of promoting efficient rates of -1 PRF.  Employing a cutoff 
of 1% (i.e. approximately 20-fold above non-programmed frameshifting (122)), the 
EST2 mRNA was found to harbor three functional -1 PRF signals, EST1 contains 
two, and STN1 and CDC13 each have one (Table 2).  To ascertain whether -1 PRF 
promoted by these sequences adhered to canonical simultaneous slippage mechanism 
(123), the slippery sites were silently mutagenized so that they would disrupt the 
slippery sequences while still encoding the same peptide sequences.  While none of 
these slippery site mutations completely abrogated -1 PRF, they all reduced rates of 
frameshifting 3 to 6 fold. The residual -1 PRF promoting activities can be accounted 
for by the fact that the constraints imposed by silent mutagenesis retained 






aORF bPosition cSlippery site  
Silent slip site Mut (ssM) 
d% -1 PRF efficiency 
% -1 PRF ssM 
L-A virus 
gag/pol 
1969 G GGU UUA 
ND 
6.5% + 0.62 
 
EST1 1203 U UUU UUU 
ND 
0.10 + 0.08 
1272 A AAA AAC 
G AAG AAC 
6.33 + 0.71  
1.29 + 0.18 
1920 A AAA AAA 
G AAG AAC 
1.73 +  0.03 
0.83 +  0.15 
EST2 72/75 A AAU UUA  AAA 
ND 
0.58 + 0.04 
1215 C CCU UUU 
U CCA UUC 
10.65 + 0.1.0 
1.44 +  0.14 
1326 A AAA AAA 
G AAG AAC 
1.40 + 0.04 
0.66 + 0.03  
1653 A AAA AAU 
G AAG AAC 
67.15 +  2.86  
13.12  + 1.79 
1995 U UUA AAA 
ND 
0.54 + 0.04 
STN1 885 U UUU UUU 
ND 
0.04 + 0.07 
1203 A AAA AAU 
G AAG AAC 
24.36 + 1.19 
3.23 + 0.16 
CDC13 1272 U UUU UUC 
C UCU UUC 
4.20 + 0.04 
2.94 + 0.03 
 
Table 2. Most predicted -1 PRF signals in ORFs involved in yeast telomere maintenance 
promote efficient -1 PRF in yeast cells. 
   a Yeast gene. bPosition in the ORF of the first nucleotide of the predicted -1 PRF signal.  
Note that 72/75 represents a tandem slippery site beginning at nt 72 of the EST2 ORF. 
cSlippery site sequence of the predicted -1 PRF signal.  Below these are shown silent protein 
coding slippery site mutants (ssM). ND indicates slippery site mutants that were not assayed 
because the wild-type sequence was determined to not promote efficient -1 PRF.   dPredicted 
frameshift signals were cloned in dual luciferase reporters, and -1 PRF efficiencies were 
monitored in yeast cells. Upper lines show mean and standard deviations of % -1 PRF 





The -1 PRF signals in the EST1, EST2, STN1 and CDC13 mRNAs respond to 
cellular mutations and drugs that globally affect -1 PRF.   
 
We have previously characterized a large number of yeast mutants that globally alter 
rates of -1 PRF (124).  To independently test whether these sequences promote -1 
PRF by the canonical mechanism, rates of -1 PRF were assayed in isogenic cells 
expressing alleles of RPL3 or RPL10 or NMD3  that had previously been shown to 
stimulate or inhibit -1 PRF as directed by the L-A virus derived sequence 
(125)(126)(127). As shown in Figure 17A, rates of -1 PRF directed by all of the 
sequences were stimulated in cells expressing the rpl3-mak8 allele while it was 
uniformly inhibited in cells expressing the rpl3-R247A allele of RPL3.   Similarly, the 
yeast strains expressing rpl10-R98S and  rpl10-R98S+NMD3-Y379D alleles of 
RPL10 and NMD3 enhanced rates of -1 PRF directed by all of the sequences in 
question (Figure 17B).  Previous studies have demonstrated that rates of -1 PRF can 
also be affected by the peptidyltransferase inhibitor anisomycin (128).  Consistent 
with the hypothesis that these are canonical -1 PRF signals, anisomycin uniformly 
inhibited -1 PRF directed by all of the sequences, and the extent of -1 PRF inhibition 
was dose-dependent (Figure 17C).  In sum, these data support the hypothesis that 









Figure 17.  -1 PRF signals in the yeast EST1, EST2, STN1 and CDC13 mRNAs respond 
to cellular mutants (panels A and B) and a drug (panel C) that were previously found to 
promote changes in -1 PRF promoted by viral -1 PRF signals. 
-1 PRF was monitored using dual luciferase reporters [26] in isogenic cells expressing RPL3 
alleles or (panel B) isogenic cells expressing RPL10 alleles. All assays were performed 
enough times to generate meaningful statistical data [52]. Error bars represent standard error. 
Note that the following the gene name denotes the specific mRNA and first nucleotide of the 
-1 PRF signal. This nomenclature is used throughout. 
 
A                                                                       B 





mRNA destabilization activity is inversely correlated with the strength of 
individual -1 PRF signals.  
 
Analysis of the predicted outcomes of -1 PRF events suggests that >95% of the 
genomic -1 PRF signals should direct translating ribosomes to premature termination 
codons suggesting that -1 PRF could be used to post-transcriptionally regulate gene 
expression through the nonsense-mediated mRNA decay (NMD) pathway (129)(130).  
In a series of proof-of-principle experiments using the well-defined -1 PRF signal 
from the yeast dsRNA L-A virus we demonstrated that: 1) this signal can function as 
an mRNA destabilizing element; 2) mRNA destabilization requires the presence of a 
functional -1 PRF signal; 3) mRNA destabilization requires an intact NMD pathway, 
and; 4) mRNA half-life is inversely proportional to the frequency of -1 PRF (i.e. the 
greater the rate of -1 PRF, the greater the frequency of ribosomes being directed to a 
nonsense codon and vice versa) (96).  These principles were subsequently shown to 
apply to -1 PRF signals identified in 4 endogenous yeast mRNAs (97). To test 
whether the -1 PRF signals examined in the current study were also capable of 
functioning as NMD-dependent mRNA degradation signals, they were cloned into a 
yeast PGK1-reporter and their effects on PGK1 mRNA steady state abundances were 
assayed in isogenic UPF1 and upf1Δ  cells as previously described (97).  The 
presence of an in-frame PTC reduced PGK1 reporter mRNA abundance to 6.0% + 
0.3% of the readthrough control levels, and this was 14.8 + 0.6-fold more abundant in 
an isogenic upf1Δ strain.  The strong EST3_1653 -1 PRF signal also significantly 




readthrough levels), and was stabilized 21.8 + 2.8-fold in the upf1Δ strain 
background.  As rates of -1 PRF decreased, the effects of these elements on mRNA 
abundance also decreased.  The STN1_1203 and EST2_1215 -1 PRF signals (~24% 
and ~11% -1 PRF efficiency respectively) resulted in ~60% and ~40% reductions of 
PGK1 mRNA reporter abundance in wild-type cells (0.32 + 0.01 and 0.49 + 0.03-fold 
readthrough), and were stabilized 3.22 + 0.01 and  2.44 + 0.03 and ~ 1.74 fold in 
upf1Δ  cells.  The EST1_1272 element (~6% -1 PRF) promoted an ~40% decrease in 
reporter mRNA abundance (0.61 + 0.02-fold readthrough), which was stabilized 1.42 
+ 0.06-fold in upf1Δ cells, and the CDC13 -1 PRF signal (~4% -1 PRF) promoted an 
~20% reduction in PGK1 reporter mRNA abundance (0.81 + 0.13-fold readthrough), 
while deletion of UPF1 resulted in a 1.19 + 0.02- fold stabilization of this mRNA.  
Finally, as -1 PRF rates approached 1% EST1_1920), the reductions in PGK1 
reporter mRNA abundance were in the range of only 10% (0.91 + 0.02-fold 
readthrough), and NMD did not appear to be a significant factor (0.94 + 0.11).  
Graphic analyses of these data reveal exponential relationships between -1 PRF 
efficiency and mRNA abundance (Figure 18A) which is mirrored by increased 
abundance of the reporter upon ablation of NMD (Figure 18B).  
 
Steady-state abundance of the cellular EST1, EST2, STN1 and CDC13 mRNAs 
is inversely affected by changes in global rates of -1 PRF.   
 
Consistent with the hypothesis that the presence of operational -1 PRF signals renders 
these mRNAs substrates for NMD, all four have been previously shown to be 




by applying qRT PCR methods to total mRNAs isolated from isogenic wild-type and 
upf1Δ upf2Δ upf3Δ cells (Figure 18A). 
  
Figure 18. Delineation mathematical relationships between -1 PRF and mRNA 
abundance in wild-type (Panel A), and NMD-deficient cells (Panel B). 
The -1 PRF signals from the yeast EST1, EST2, STN1 and CDC13 mRNAs were cloned into 
yeast PGK1 reporters in their native orientations so that frameshift events would direct 
elongating ribosomes to premature termination codons (PTC).  A PGK1 vector without 
inserted sequences was used as a control. These reporters were transformed and expressed in 
isogenic wild-type (A), or upf1Δ cells (B), and mRNA steady-state abundances were 
determined by qRT-PCR using the endogenous yeast U3 snoRNA as an internal standard. (A) 
Steady-state abundances of -1 PRF signal containing PGK1 reporter mRNAs/PGK1 control 
mRNA (i.e. no -1 PRF) in wild-type cells, fit to a logarithmic function.  (B)  Steady-state 
abundances of -1 PRF signal containing PGK1 reporter mRNAs in isogenic upf1Δ versus 
UPF1 cells fit to a logarithmic function. Error bars denote standard deviation.   
 
Given the ability of -1 PRF signals to affect the abundance of the PGK1 reporter 
mRNA, we tested the hypothesis that global changes in -1 PRF rates would similarly 
affect the steady-state abundance of these mRNAs. qRT-PCR analysis of total RNAs 
isolated from isogenic cells expressing rpl3-mak8, rpl3-R247A, or rpl10-R98S and  
rpl10-R98S+NMD3-Y379D mutants revealed an inverse correlation between changes 
in -1 PRF and the steady-state abundances of the EST1, EST2, STN1 and CDC13 
mRNAs (Figure 19B).  Specifically, the steady-state abundances of these mRNAs 
were decreased when -1 PRF was globally increased (rpl3-mak8, rpl10-R98S and 




inhibited.  The steady-state abundances of these mRNAs were also assayed in the 
presence of increasing concentrations of anisomycin.  Similarly, their steady-state 
abundances were increased in a dose dependent manner, i.e. as -1 PRF rates 






























Figure 19. Steady-state abundances of native EST1, EST2, STN1 and CDC13 mRNAs in 
mutant and drug treated cells. 
 qRT PCR was used to determine steady state abundances of the native mRNAs using the 
G3PD mRNA as an internal standard. (A) mRNA abundances were monitored in isogenic 
UPF1 and upf1∆ upf2∆ upf3∆ cells. (B) mRNA abundances in isogenic wild-type and rpl3-
mak8-1, rpl3-R247 (compared to wild-type RPL3), and rpl10-R98S and rpl10-R98S+NMD3-
Y379D (compared to RPL10-NMD3) cells. (C) mRNA abundances were monitored in wild-











Alteration of -1 PRF in the EST2 mRNA results in telomeres of intermediate 
length and accumulation of large, multiply budded cells.   
 
One would expect that overexpression of telomerase would lead to longer telomeres.  
However, previous studies made the intriguing finding that telomeres are very short 
in NMD-deficient cells, and that overexpression of EST2, STN1 or CDC13 resulted in 
telomeres of intermediate length (133)(134)(135).  To test if this is linked to -1 PRF 
and mRNA stability, isogenic est2Δ, upf2Δ  and est2Δ /upf2Δ  cells were transformed 
with low copy (CEN6) vectors expressing full-length EST2 (pEST2), or one 
containing silent protein coding slippery site mutants (ssM).  The mRNA produced 
from this mutant was previously shown to be ~8.5-fold more abundant than that 
transcribed from pEST2 (136).  Genomic DNAs were harvested, digested with Pst I, 
and a Southern blot was probed for yeast telomeric sequences as previously described 
(133).  Consistent with previous reports, complementation with the wild-type EST2 
clone restored long telomeres (L) in est2Δ cells, and ablation of NMD uniformly 
resulted in short telomeres (S) (Figure 20A).  Importantly, expression of pEST2ssM 
as the sole source of Est2p promoted intermediate length telomeres (indicated by “I”), 
recapitulating the EST2, STN1 and CDC13 overexpression observations. These 
findings establish a linkage between -1 PRF and telomere length homeostasis through 
NMD in yeast. 
Short telomeres create a “crisis” for dividing cells, triggering a series of signals that 




to restore their telomeres before committing to division (reviewed in (137)). Cells 
arrested at this “checkpoint” can continue to grow, increasing in volume, and 
eventually they can bypass mitosis, producing multiply budded yeast cells. 
 
Figure 20.  Ablation of -1 PRF in EST2, or of NMD affects telomere length and 
promotes G2/M cell cycle arrest.  
(A) Southern blot of Pst I digested DNAs isolated from isogenic wild-type, upf1Δ , est2Δ , or 
upf1Δ  est2Δ  cells were transformed with either an empty CEN6 low copy vector (vector), 
the same vector expressing the wild-type EST2 gene (pEST2), or one in which the slippery 
sites of all 5 tested -1 PRF signals had been silently mutated (see Table 1).  The blot was 
probed using DNA oligonucleotides complementary to telomeric repeat sequences as 
described [33].  Letters along the right hand side indicate Long, Intermediate, and Short 
telomeres respectively.  (B) Phase contrast microscopy (100x) of cells used in panel A 
harvested from logarithmically growing cultures. 
 
  In unpublished observations, we had noted that NMD-deficient cells tend to be 
unusually large and accumulate with large daughter buds suggestive of a G2/M 
mitotic delay.  In combination with the results presented above, this led to the 
hypothesis that NMD-dependent defects in telomerase expression might affect the 
cell cycle.  If true, then overexpression of Est2p by the pEST2ssM construct should 
confer a similar phenotype.  This is indeed what we observed:  est2Δ cells expressing 




also displayed the large daughter bud phenotype.  This phenotype was exaggerated in 
est2Δ upf1Δ cells expressing either pEST2 or pEST2ssM (Figure 20B).  These 
findings suggest that -1 PRF may play an important role in controlling the cell cycle 
through telomerase expression. 
 
-1 PRF signals as classic, rapidly evolving cis-acting elements. 
 
A prior analysis of -1 PRF signals from BUB3, EST2, SPR6 and TBF1 orthologs the 
closely related yeast species S. paradoxus, S. mikatae, S. bayanus, S. castellii, S. 
kudriavzevii and S. kluyveri suggested that while no specific −1 PRF signals appeared 
to be conserved among these orthologs, the presence of high probability predicted -1 
PRF signals in the orthologs of all of these genes (although not in every species) 
suggested that the mechanism itself may be conserved in these families of mRNAs, 
an observation that was supported by the finding that no -1 PRF signals were found in 
any of the orthologs of six genes that were found to lack predicted −1 PRF signals in 
S. cerevisiae (PGK1, HHT1, TEF2, MIC14, CMD1 and GRX1) [24]. To address 
whether -1 PRF may be a conserved mechanism in yeast telomere maintenance, the 
orthologous genes for EST1, STN1, and CDC13 were queried.  These data are 
presented in Appendix 7.  One potential -1 PRF signal was found in the EST1 
orthologs from S. paradoxus, S. bayanus, and S. mikatae, but the EST1 mRNAs from 
S. castelli, S. kluyveri and S. kudriavzevii lacked predicted -1 PRF signals.  Potential -
1 PRF signals were found in the STN1 orthologs from S. paradoxus, S. bayanus, S. 
castelli and S. kluyveri but not in S. mikatae or S. kudriavzevii.  Similarly, 




were found to harbor potential -1 PRF signals, but those from S. bayanus and S. 
kudriavzevii did not. The potential evolutionary significance of these observations are 
discussed below.  
Functional -1 PRF signals in three human messages encoding proteins required 
for telomere maintenance. 
 
A search for -1 PRF signals in mRNAs encoding proteins involved in the human 
telomere maintenance revealed candidate frameshift signals in the TERF2, TERF2IP 
and SMG6 open reading frames (Figure 21). TERF2 protein is a component of the 
telomere nucleoprotein complex called the shelterin complex (telosome) (138). It is 
present at the telomere repeats and plays a protective role by preventing telomere 
shortening and end-to-end fusions of the chromosomes (139)(140). TERF2IP is also a 
component of the shelterin complex and binds to the telomere ends through 
TERF2(140). It plays a major role in telomere capping (141)(142). SMG6 is the 
human homolog of the yeast EST1 (143). Besides its involvement in telomere end 
capping, SMG6 also serves as an endonuclease in the process of NMD at the 



















Figure 21. Sequences of -1 PRF signals in three human messages encoding proteins 
required for telomere maintenance. 
The figure shows the predicted -1 PRF signals in human mRNAs encoding TERF2, TERFIP 
and SMG6 protein involved in human telomere maintenance. The numbers indicate the 
position in the ORF of the first nucleotide of the frameshift signal. 
 
These candidate -1 PRF signals were cloned in mammalian dual luciferase reporter 
and -1 PRF efficiencies were monitored in HeLa cells. Again, employing cutoff of 
1%, we observe that all the three candidate frameshift signals promote significant 
rates of -1 PRF ranging from ~1.73% for SMG6 to ~10.34% for TERF2 (Table 3). 












aORF bPosition cSlippery site d% -1 PRF 
efficiency 
TERF2 468 A AAU UUA 10.34%   +1.19% 
TERF2IP 1108 A AAA AAU 7.45%   +0.72 
SMG6 715 C CCA AAC 1.73%     +0.17 
 
Table 3. Predicted -1 PRF signals in ORFs involved in human telomere maintenance 
promote efficient -1 PRF in yeast cells. 
 a Human gene. bPosition in the ORF of the first nucleotide of the predicted -1 PRF signal. 
cSlippery site sequence of the predicted -1 PRF signal. dPredicted frameshift signals were 




It is now clear that the canonical -1 PRF signals consisting of a heptameric slippery 
site closely followed by an mRNA pseudoknot that were first characterized in RNA 
viruses are also widely utilized in eukaryotic cellular mRNAs.  Furthermore, it is also 
well established that, by shifting translating ribosomes to premature termination 
codons, these elements have mRNA destabilizing activities through the NMD 
pathway. Here, we have investigated the potential biological relevance of such 
frameshifting by identifying and characterizing -1 PRF signals in mRNAs encoding 
yeast proteins involved in telomere maintenance.  The active -1 PRF signals in the 
mRNAs encoding Est1p, Est2p, Stn1p and CDC13p function as mRNA destabilizing 
elements through NMD.  Interestingly, the wide range of -1 PRF efficiencies 
promoted by the seven different -1 PRF signals enabled a mathematical analysis of 
the relationship between -1 PRF and mRNA steady-state abundances (Figure 19).  
The inverse-exponential correlation between -1 PRF and mRNA abundance suggests 
that there are limits to changes in -1 PRF above or below which biological effects 
may be seen.  In addition, a phylogenetic analysis revealed that -1 PRF signals in 




associated mRNAs in the yeasts.  This is consistent with our previous analyses of -1 
PRF signals in other yeast genes (136).          
 
How chromosome ends are stably maintained is one of the central questions of 
modern biology (reviewed in (121)). Telomeres are thought exist in a range of states, 
from fully capped full-length, to uncapped and short (see model, Figure 22, adapted 
from models proposed in(137)(145)).  As telomeres age, they progressively shorten, 
and at some point reach an intermediate, uncapped status.  In yeast, telomere shorting 
promotes recruitment of the MRX+Tel1p and CST complexes (where C = Cdc13p, 
Stn1p, Ten1p), inducing checkpoint arrest at the G2/M boundary.  Phosphorylation of 
Cdc13p by Tel1p enables recruitment of telomerase through Est1p, stimulating 
telomere repair, and releasing cells from checkpoint arrest.  Failure to recruit 
telomerase leads to further telomere shortening, where they eventually resemble 
double-stranded breaks (DSB).  These short telomeres recruit the DSB repair 
machinery, resulting in strong checkpoint arrest.  Eventually, these short telomeres 
are maintained by this machinery, resulting in telomere end joining, and bypass of 
checkpoint arrest.  The net effect is to “immortalize” telomeres, resulting in longer 
lifespans, but at the cost of genome integrity.  Previous studies have shown that 
telomerase is limited in yeast, presumably as a means to ensure its recruitment to 
uncapped telomeres (146)(147).  Importantly, defective expression of individual 
components of yeast telomerase or telomerase recruiting proteins affects telomere 
length.  For example, overexpression of TLC1 resulted in very short telomeres (148), 




intermediate telomere length phenotype. Furthermore, ablation of NMD resulted in 
short telomeres (128)(134)(149), suggesting that the NMD pathway is downstream to 
the activities of individual protein components of the telomere repair machinery.  
Here, we have demonstrated the presence of operational -1 PRF signals in the EST1, 
EST2, STN1 and CDC13 mRNAs.  One result of -1 PRF events on these mRNAs is 
to direct elongating ribosomes to premature termination codons, consistent with the 
fact that they are substrates for NMD (Figure 20A). We have shown that these -1 
PRF signals function as mRNA destabilizing elements in an NMD-dependent 







Figure 22. Model: telomerase recruitment to uncapped telomeres is controlled by the 
relative stoichiometries of telomerase components in yeast. 
Yeast telomeres exist in a range of states, from fully capped and full length to uncapped and 
short.  As telomeres age, they progressively shorten, and at some point reach an intermediate, 
uncapped status, recruiting the MRX+Tel1p complex.  Tel1p phosphorylates Cdc13p (part of 
the Cdc13, Stn1, Ten1 complexes shown as TSC), promoting telomerase recruitment through 
Est1p, and inducing checkpoint arrest at the G2/M boundary.  Telomerase recruitment 
stimulates telomere repair (up arrow on left), and releases cells from checkpoint arrest.  
Failure to recruit telomerase leads to further telomere shortening (down arrow on right), 
where they eventually resemble double-stranded breaks (DSB-like).  These short telomeres 
also promote checkpoint arrest, but since they cannot recruit telomerase they enter crisis.  
Recruitment of the DSB repair machinery promotes chromosome end joining in some cells, 
where homologous recombination is used to amplify telomere sequences enabling checkpoint 
bypass.  We propose that maintaining the correct stoichiometric ratios of telomerase 
components is critical for telomerase recruitment and telomere length homeostasis.  
Alteration in the expression of one of these factors, e.g. overexpression of Est2p by ablation 
of -1 PRF, weakly inhibits telomerase recruitment resulting in accumulation of shorter, 
intermediate length telomeres and accumulation of cells arrested at G2/M.  Overexpression of 
all of these factors by inactivation of NMD has strong dominant-negative effects on 
telomerase recruitment, increasing the proportion of cells with short telomeres with similarly 





Consistent with these observations, the steady-state abundances of the native EST1, 
EST2, STN1 and CDC13 mRNAs are inversely correlated with changes in -1 PRF 
(Figures 19B, 19C).  Intriguingly, the mRNA encoding the third protein component 
of yeast telomerase, Est3p, harbors a +1 PRF signal (150) and is stabilized in NMD-
deficient cells (133)(132).  We propose that -1 PRF plays a role in maintaining the 
correct stoichiometric ratios of telomerase components critical for telomerase 
recruitment.  Overexpression of any one of these components, e.g. by ablation of -1 
PRF in the EST2 mRNA, has dominant-negative effects on telomerase recruitment, 
resulting in accumulation of intermediate length telomeres (see pEST2ssM expressed 
in est2Δ cells, Figure 20A).  Furthermore, we suggest that global overexpression of 
all of these components by inactivation of NMD further increases the rate of telomere 
shortening, hastening the formation of DSB-like, i.e. short telomeres.  This model 
also accounts for the observation that that ablation of -1 PRF in the EST2 mRNA, or 
ablation of NMD resulted in accumulation of large budded cells, a hallmark of 
checkpoint arrest at the G2/M boundary (Figure 20B).    
We are not unaware that these studies pose more questions than they answer.  In 
particular, we hope that this report inspires deeper research into the impact of -1 PRF 
in yeast telomere maintenance by laboratories better equipped for such inquiry.  More 
broadly, our studies suggest that -1 PRF is a fundamental molecular mechanism that 
is used to fine tune a myriad of physiological processes.  The big questions in the 
field that need to be addressed in the future include: 1) which mRNAs are actively 
engaged in -1 PRF in which cell types? 2) Where along these mRNAs are ribosomes 




have meaningful biological effects? And 4) how and in response to what stimuli can -
1 PRF be regulated? The answers will have broad impact over the next decade. 
Methods Summary 
 
Strains, genetic manipulations, and media.  Escherichia coli DH5α was used to 
amplify plasmid DNA.  Transformations of E. coli were performed as described 
previously using the calcium chloride method (151).  Yeast cells were transformed 
using the alkali cation method (152).  Yeast strains used in this study are shown in 
Appendix 1.  Yeast were grown on YPAD and synthetic complete media (H-) (153).  
 
Plasmids and assays of -1 PRF and mRNA steady state abundance.  URA3-based 
high copy dual luciferase and mRNA stability plasmids were previously described 
(129).  Oligonucleotide primers were purchased from IDT (Coralville, IA).  
Computationally identified putative -1 PRF signals shown in (Figure 15) were 
amplified from yeast genomic DNA by PCR using oligonucleotide primers which 
terminated in a Sal I restriction site at the 5’ and Bam HI at the 3’.  The zero-frame 
dual-luciferase reporter plasmid (pJD375) along with the -1 PRF signal containing 
dsDNA fragments were digested using these restriction enzymes and ligated together 
to generate endogenous -1 PRF signal containing dual-luciferase vectors.  The wobble 
bases of slippery heptamers were mutagenized to synonymous codons in dual 
luciferase reporters by oligonucleotide site-directed mutagenesis using the 
QuickChange® Lightning Site-Directed Mutagenesis Kit (Agilent). PGK1 reporter 
constructs for individual -1 PRFs were made as previously described (136). Read 




were used as controls for PGK1 reporter steady state assays.  Oligonucleotide primers 
were chosen to terminate in Kpn I restriction sites and amplify 41 and 30 bases of 
Renilla and firefly luciferase derived sequences respectively.  The resulting 
amplicons were cloned into the Kpn I site 492 bases into the PGK1 open reading 
frame of the unmodified PGK1 containing vector (pJD741).  A premature termination 
codon vector (pJD828) was generated by cutting the readthrough (pJD753) with 
BamHI and backfilling with Klenow fragment.  Plasmids expressing full length EST2 
and the EST2ssM mutant were previously described (136). Assays to determine rates 
of -1 PRF and mRNA steady-state abundances were performed as previously 
described.  Plasmids used in this study are listed in Appendix 2.  
 
Southern Blot analyses of est2 mutants.  Full length EST2 expression vectors 
(pJD641), EST2 mutant vectors (pJD796), and null plasmids (pJD315) were 
transformed into WT (JD1281), EST2 deletion (JD1287), UPF2 (JD1288) and 
EST2/UPF2 (JD1276) deletion strains.  Southern analyses were performed as 
described previously (134)(154) Genomic DNA was extracted from mid-logarithmic 
cell cultures and Pst I was used to diegest DNA in 10 µg aliquots.  The resulting 
fragments were separated on a 1% agarose gel and transferred to a Hybond-N-
membranes (Amersham) and hybridized to a probe derived from yeast telomeric 
DNA.  This probe was prepared from pBC6 (a gift from the Berman lab) by PCR 
amplifying the telomeric region using M13 oligos.  The resulting linear amplicon was 
used as template to create α [32P] internally labeled telomeric TG repeat sequence 




using a GeneStorm phosphoimager (Bio-Rad) and quantified using QuantifyOne 
(Bio-Rad). 
 
Microscopic methods.  Yeast cells were visualized using a Zeiss Aziphot microscope 
at 100x magnification.   
 
Phylogenetic analyses 
The EST1, STN1 and CDC13 orthologs from the genomes of S. paradoxus, S. 
mikatae, S. bayanus, S. castellii, S. kudriavzevii and S. kluyveri were extracted from 
the Yeast Gene Order Browser (http://wolfe.gen.tcd.ie/ygob/)(155). Orthologs were 
identified for all genes and nucleotide sequences were analyzed for the presence of 
potential −1 PRF signals as previously described[16;23].  Results are compiled in 
Appendix 7.  
 
Mammalian Dual-luciferase assays. 
 The dual-luciferase reporters containing the TERF2, TERF2IP and SMG6 −1 PRF 
signals were made using the modified DNA fragment assembly protocol of In-
Fusion HD cloning kit from Clontech.  Mammalian dual-luciferase reporters were 
transfected into HeLa cells using FuGene HD transfection reagent. Translational 










Ribosome is a large and complex molecular machine that decodes the information in 
the mRNA to make proteins from amino acids during the process of translation. 
Translational control is the most important aspect of post-transcriptional gene 
regulation and has strongest the effects on the mRNA abundance and hence protein 
levels.  A yeast cell contains more than 200,0000 ribosomes in the cytoplasm and the 
cell produces up to 2000 ribosomes per minute to meet the protein synthesis demand 
of the cell (157). The yeast 80S ribosome consists of approximately 5500 nucleotides 
of rRNA and 79 ribosomal proteins (158,159).  Over 200 accessory proteins and 
transacting factors are involved in ribosome biogenesis and over 35 proteins interact 
with the ribosome during canonical translation process (100)(104). Many proto-
oncogenes and tumor suppressors are direct regulators of the translational apparatus 
(160)(161). Defects in the translational apparatus have been associated with a class of 
human diseases collectively called ribosomopathies. Ribosomopathies are typified as 
congenital diseases caused by structural and functional defects of the ribosomal 
components. The ribosomopathies are characterized by a spectrum of abnormalities 
including anemias, ataxias, mental retardation, connective tissues disorders and 
elevated risk of developing cancer (162)(163) Ribosomopathies are linked to 
mutations in genes associated with ribosomal proteins, rRNA processing, ribosome 




syndrome (DBA) is associated with mutations in the genes encoding ribosomal 
proteins S19, S26, S24, L5 and L11 (165)(166). DBA is characterized by 
normochromic macrocytic anemia, growth retardation and other congenital disorders. 
DBA patients have an elevated risk of hematopoietic neoplasms and osteogenic 
sarcomas (167). 
Relevant to this study is X-linked Dyskeratosis Congenita (X-DC), a ribosomopathy 
caused by mutations in DKC1, the mammalian gene encoding dyskerin (168). The 
homolog in yeast is named CBF5. X-DC is characterized by several mucocutaneous 
abnormalities (skin pigmentation, nail changes etc.), pulmonary fibrosis, bone 
marrow failure, increased susceptibility to cancer and rapid ageing (105)(169)(170). 
Pursuant to the aging phenotype, X-DC patients have radically reduced telomere 
lengths (171)(172). Dyskerin (and Cbf5p in yeast) is the pseudouridine synthase and 
forms the catalytic core of the larger H/ACA ribonucleoprotein complex that 
catalyzes the isomerization of uridine to pseudouridine (ψ) in rRNA (173)(174). 
Pseudouridylation is the most common single nucleotide modification of the 
ribosomal rRNA and is conserved from bacteria to humans (173)(175)(176)(177). 
The yeast rRNA contains 44 pseudouridine (ψ) residues (Figure 23) that are 
important for proper assembly and function of the ribosome (178). The pseudouridine 
bases are clustered around functionally important regions of the ribosome,  including 
the peptidyl transferase center, the decoding center, A-, P- and E-sites of the large and 
small subunits, and the mRNA platform (103)(179). In yeast, substitution of aspartic 
acid at position 95 in the catalytic domain of Cbf5p (cbf5-D95A) abolishes in vivo 




The hypo-pseudouridylated ribosomes in cbf5-D95A mutant have decreased affinity 
for both A- and P-site tRNAs and CrPV IGR IRES (106)(182).  It has been shown 
that ψ defects in cbf5-D95A mutant in yeast, DKC1m cells in mice and siRNA 
knockdown of DKC1 in human cells promote translational fidelity defects. These 
include increased rates of -1 PRF and decreased UAA (stop codon) readthrough 
(106).  
Spinocerebellar ataxia type 26 (SCA26) is an autosomal dominant neurodegerative 
disorder (183). It is one of the 31 subtypes of SCAs characterized by late onset 
Purkinje cell death and atrophy of the cerebellum (184)(185). The single variant that 
co-seggregated with SCA26 defect was identified as C->A transversion in the 
ubiquitously expressed elongation factor 2 (eEF2) open reading frame. This 
transversion generates proline to histidine substitution at position 596. The yeast 
equivalent mutation in eEF2 is P580H (107). The yeast P580 lies in domain IV 
adjacent to H699 which is the diphthamide-bearing moiety that interacts with the 40S 
ribosomal subunit (Figure 23). The P596H variant of eEF2 in human cells does not 
cause destabilization or mislocalization of the protein. However, the P580H mutant in 
yeast promoted increased rates of -1 PRF as directed by the yeast L-A viral -1 
frameshift signal. 
An outstanding question is how ‘defective’ translation can produce specific 
pathological features. Preliminary findings suggest these genetically inherited defects 
result translational fidelity defects (i.e. changes in rates of -1 PRF, +1 PRF, and stop 




telomere maintenance. These studies establish a paradigm for understanding the 


















Figure 23. Causative mutations in X-DC and SCA26. 
(A) Shows the locations of 44 pseudouridine bases on the rRNA as red dots. 
Pseudouridylation is the single most common modification of rRNA and is conserved from 
yeast to humans. X-DC is a ribosomopathy caused by various mutations in the DKC1 gene 
(CBF5 is the yeast homolog) encoding pseudouridine synthase. These mutations result in 
hypopseudouridylation of the rRNA. This figure is from (106) (B) Diagram of the crystal 
structure of EF2 in complex with the yeast 40S ribosomal subunit. SCA26 is caused by the 
eEF2-P596H mutation. The yeast equivalent mutation is P580H. The P580 amino acid is 










Mutations associated with X-DC and SCA26 promote increased rates of -1 PRF 
and decreased rates of +1 PRF.  
Maintenance of the translational reading frame is an important aspect of the 
translational fidelity. As described in Chapter 2, functional -1 PRF signals were 
identified in the mRNAs encoding Est1p, Est2p, Stn1p and Cdc13p involved in yeast 
telomere maintenance (186). The cbf5-D95A, eEF2-P580H and eEF2-H699Q 
mutants had been previously shown to stimulate -1 PRF directed by L-A virus 
derived sequence using bicistronic reporter assay (106)(107). As shown in (Figure 
24A) these mutants also enhanced rates of -1 PRF directed by frameshift signals in 
yeast telomere maintenance genes EST1 (beginning at nucleotide 1272), EST2 
(beginning at nucleotide 1215), STN1 (beginning at nucleotide 1203) and CDC13 
(beginning at nucleotide 1272). Previous studies have shown that -1 PRF as directed 
by frameshift sequences derived from HIV-1 and human CCR5 and IL-7RA genes is 
enhanced in HeLa cells with siRNA-mediated knockdown of DKC1. Consistent with 
this, we show that siRNA-mediated knockdown of DKC1 in human cells increased 
IL-2RG promoted -1 PRF by 1.8-fold (Figure 24B). Moreover, -1 PRF was also 
enhanced ~1.8 fold for HIV-1 and ~2.2 fold for CCR5 frameshift signals in SC26 
patient derived LCL cells (Figure 24C). The +1 PRF directed by the yeast Ty1 
retrotransposable element is inhibited in cbf5-D95A and eEF2-P580H cells (Figure 
24D). Altogether, these results suggests that frame maintenance defects associated 





Figure 24. Dual Luciferase reporter assays to monitor -1 PRF and +1 PRF in yeast and 
human cells. 
-1 PRF rates were measured in yeast strains (A) expressing cbf5-D95A allele of CBF5 or 
eEF2-P580H and eEF2-H699Q alleles of eEF2 using frameshift signals in yeast telomere 
maintenance genes EST1, EST2, STN1 and CDC13. (B) and (C) -1 PRF efficiency was 
monitored in HeLa cells transfected mock, scrambled or DKC1 siRNA or normal and SCA26 
patient derived LCL cells using frameshift signals in HIV-1, human CCR5 and IL-2RG. (D) 
+1 PRF rates were measured in yeast strains using frameshift signal derived from yeast Ty1 
retrotransposable element. Error bars denote standard error. All results are expressed as fold 
WT. *P < 0.05, **P < 0.01. 
 
Mutations associated with X-DC and SCA26 promote enhanced recognition of 
stop codon. 
In vivo dual luciferase assays were also used to monitor the in-frame stop codon 
readthrough in both yeast and human cells. In general, all the yeast mutants under 
consideration promoted increased fidelity at the three termination codons as 
compared to their respective isogenic wild type. The cbf5-D95A mutant recognized 




type cells, consistent with the earlier work performed by Jack et. al. (106) (Figure 
25A). The SCA26 associated P580H mutation promoted ~30% and ~25% increased 
fidelity at UAA and UAG codons respectively (Figure 25A). Similarly, human cells 
with siRNA knockdown of DKC1 also exhibited enhanced recognition at the stop 
codons (Figure 25B). Hence, the defects in reading frame maintenance and stop 
codon recognition associated with X-DC and SCA26 mutations are conserved in both 
yeast and human cells. 










Figure 25. Dual luciferase reporter assays to monitor in-frame stop codon readthrough 
in yeast and human cells. 
Stop codon readthrough rates were measured in (A) yeast expressing cbf5-D95A allele of 
CBF5 or eEF2-P580H and eEF2-H699Q alleles of eEF2 and (B) in HeLa cells transfected 
with DKC1 siRNA. All results are expressed as fold WT (or mock). Error bars denote 
standard error. *P < 0.05, **P < 0.01.  
 
Increased fidelity at stop codons results in more efficient clearance of NMD 
substrates. 
Nonsense mediated mRNA decay pathway (NMD) maintains transcriptome fidelity 
by rapidly clearing cells of mRNAs containing premature termination codons (PTC). 
The components of NMD interact with the release factors to enhance termination and 
degrade aberrant mRNAs (187). Transcripts with uORFs and long 3’UTRs are also 








The efficiency of NMD is dependent on the fidelity of the translation termination 
(188)(189). Therefore, enhanced recognition of the termination codons in D95A, 
P580H and H699Q mutants are expected to cause increased clearance of substrates of 
NMD. To test this hypothesis we used the yeast PGK1 reporter system, where the 
readthrough PGK1 reporter encodes a continuous transcript that is highly stable (97), 
while introduction of an in-frame UAA termination codon results in rapid 
destabilization of the message via NMD (Figure 26A). Presence of sequences from 
Renilla and firefly luciferase genes allows for specific detection of the reporter 
transcripts. These reporters were introduced into isogenic sets of yeast cells and the 
steady state mRNA abundances were determined by qRT-PCR with U3 snoRNA as 
the loading control. The steady state mRNA abundances of PGK1 nonsense 
transcripts (normalized to the readthrough control for respective strains) were reduced 
in cbf5-D95A, eEF2-P580H and eEF2-H699Q cells (Figure 26B). Additionally 
known yeast endogenous NMD substrates GCN4 (a transcriptional activator) (190) 
and CCR4 (a dominant polydeadenylase) (191) were also destabilized in the mutant 
cells (Figure 26C). The mRNAs of GCN4 and CCR4 have uORFs and their 
abundances are regulated via NMD (192)(72). Thus efficient decoding of the stop 
codons causes efficient clearance of NMD substrates probably due to efficient 



























Figure 26. Yeast based studies of the effects of the cbf5-D95A and eEF2 mutants on 
mRNA abundance. 
 (A) Schematic of PGK1 reporters used to monitor effects of mutations on steady-state 
abundance of PTC containing mRNAs. (B) Steady-state mRNA abundance of the 
PTC/readthrough control reporter mRNAs shown in panel A (as fold wild type cells). (C) 
Steady-state abundances of two endogenous mRNAs known to be NMD substrates (shown as 
fold wild-type cells). Error bars denote standard error. 
 
Increased rates of -1 PRF and enhanced NMD lead to shortened telomeres. 
Recent studies have shown that the steady state abundances of the -1 PRF signal 
containing cellular EST1, EST2, STN1 and CDC13 mRNAs is inversely affected by 
global changes in -1 PRF rates (186). Similarly, the steady state mRNA abundances 
of the endogenous EST1, EST2, STN1 and CDC13 mRNAs were reduced in cbf5-
D95A, eEF2-P580H and eEF2-H699Q cells as monitored by qRT-PCR (Figure 
27A). A qPCR analysis of the genomic DNA revealed reduced abundance of the 
telomere repeat sequence in cbf5-D95A, eEF2-P580H and eEF2-H699Q cells 
indicative of defects in telomere maintenance (Figure 27B). Functional -1 PRF 







signals were recently identified in human TERF2, TERF2IP and SMG6 mRNAs 
involved in telomere maintenance (Chapter 2). Consistent with the earlier findings 
siRNA-mediated knockdown of DKC1 in HeLa cells promote increased rates of -1 
PRF directed by sequences located in TERF2, TERF2IP and SMG6 mRNAs (Figure 
27C). The altered rates of -1 PRF may result into decreased abundances of the 






















Figure 27. Increased rates of -1 PRF and enhanced NMD lead to shortened telomeres. 
 (A). Steady-state endogenous abundances of EST1, EST2, STN1 and CDC13 mRNAs were 
monitored using quantitative RT-PCR in yeast strains.   (B). Relative telomere length 
measured as abundance of telomere repeat sequence quantified by RT-PCR, with the single-
copy reference gene SGS1 as the loading control. (C) -1 PRF efficiency was monitored in 
HeLa cells transfected mock, scrambled or DKC1 siRNA using frameshift signals in human 
TERF2, TERF2IP and SMG6 mRNAs. All results are expressed as fold WT or mock. Error 









There is a growing body of evidence connecting translational fidelity defects and 
human disease (127)(106)(163). Here we use X-DC and SCA26 as models to 
understand how mutations in genes associated with translational machinery may 
contribute to distinct pathological features of these lethal diseases. 
Previous studies have shown that impairment rRNA pseudouridylation in cbf5-D95A 
cells decreases ribosomal affinity for tRNAs at both the A- and P- site (106). Both A- 
and P- site tRNAs are the substrates for -1 PRF and increased rates of -1 PRF is 
consistent with the increased slippage of both tRNAs. The P580 residue of yeast eEF2 
(and P596 in mammalian eEF2) is located very close to the diphthamide moiety. The 
proline to histidine substitution likely hinders the interaction of the eEF2 with the 
ribosome thereby disrupting translocation. Consistent with recent kinetics studies 
(193) impairments in translocation would be expected to result in increased rates of -1 
PRF, consistent with the observations in yeast eft2-P580H and eft2-H699Q cells can 
be attributed to hindered translocation of the ribosome during elongation. Similarly, 
impaired translocation in these cells may result in slowed ribosomal transit time at 
termination codons, enhancing the probability of their recognition by eRF1, resulting 
in the observed increased fidelity at the stop codons in these mutants. 
Increased rates of -1 PRF in the cbf5-D95A, eft2-P580H and eft2-H699Q cells results 
in decreased steady state abundances of the endogenous EST1, EST2, STN1 and 
CDC13 mRNAs, which encode proteins involved in telomere length maintenance. 
Consequently these yeast cells have short telomeres. Additionally ψ defects also 




located in the human mRNAs encoding TERF2, TERF2IP and SMG6 proteins. 
Interestingly, preliminary data from the Ruggero laboratory suggests that TERF2 
protein expression is decreased in X-DC patient cells (Davide Ruggero, personal 
communication). These observations suggest a novel link between ribosome function 
and telomere maintenance. Computational analyses suggest that ∼10% of eukaryotic 
cellular mRNAs harbor functional −1 PRF signals (44). In the human transcriptome, 
99.93% of these are predicted to direct elongating ribosomes to a -1 frame premature 
termination codon, triggering rapid degradation of the mRNA via NMD. Thus, we 
suggest that the roots of the pathological features associated with X-DC and SCA26 
can be traced to the intrinsic translational defects that cause decreased abundance of -
1 PRF signal containing mRNAs via NMD.  
Programmed translational readthrough (PTR) is of physiological significances in 
Drosophila and human fibroblast cells (194)(195). PTR in the mRNA encoding the 
human vascular endothelial growth factor A (VEGFA) generates a 22 amino acid C-
terminally extended isoform VEGF-Ax. VEGF-Ax exhibits antiangiogenic activity 
(65). Increased fidelity at the stop codons due to rRNA ψ defects may result in 
decreased rates of PTR on this mRNA, and hence decreased VEGF-Ax synthesis 
contributing to increased susceptibility to cancer.  
NMD depends on translation efficiency (196). It plays an important role in the 
differentiation of neural and hematopoietic progenitor cells (197)(198)(199). Several 
pro-hematopoietic factors have been identified as targets of NMD and  their 
dysregulation due to aberrant activation or inactivation of NMD inhibits 




in enhanced clearance of mRNAs NMD targets (Figure 26 and 27A). These also 
include mRNAs harboring -1 PRF signals. Unpublished data demonstrates decreased 
expression of proteins involved in hematopoietic stem cell differentiation that 
contribute to bone marrow failure in X-DC patients. In sum, these findings lay a 
general framework for a proposed mechanism for X-DC, SCA26 and 
ribosomopathies. This is modeled in (Figure 28). 
 
Figure 28. General Model of Translationopathy. 
Mutations in genes that participate in translation confer translational fidelity defects. The 
translational fidelity defects include but are not limited to +1 PRF, -1 PRF and/or stop codon 
readthrough. The type and the magnitude of translational fidelity defects elicit 
downstream post-transcriptional surveillance pathways like NMD. This leads to 








Strains, genetic manipulations, and media.  Escherichia coli DH5α was used to 
amplify plasmid DNA.  Transformations of E. coli were performed as described 
previously using the calcium chloride method (151).  Yeast cells were transformed 
using the alkali cation method (152).  Yeast strains used in this study are shown in 
Appendix 1.  Yeast were grown on YPAD and synthetic complete media (H-) (153).  
 
Translational Fidelity assays 
Yeast dual Luciferase reporters harboring the yeast L-A virus −1 PRF signal, the Ty1-
derived +1 PRF signal, or in-frame UAA, UAG or UGA codon were previously 
described (122). Yeast cells were transformed using the alkali cation method (152). 
Mammalian dual-luciferase reporter containing the HIV-1, CCR5, IL-2RG, TERF2, 
TERF@IP and SMG6  −1 PRF signals or in-frame UAA, UAG or UGA codon were 
used. The mammalian dual-luciferase reporters were transfected into HeLa cells using 
FuGene HD transfection reagent. siRNA knockdown experiments in HeLa cells 
employed either mock, DKC1 or control scramble siRNA oligos. Translational 
recoding was measured as described (200). 
 
Plasmids and assays of -1 PRF and mRNA steady state abundance.  URA3-based 
high copy mRNA stability plasmids were as previously described in (136).  
Oligonucleotide primers were purchased from IDT (Coralville, IA). Read through 
PGK1 plasmid pJD753 and premature termination codon vector (pJD828) were used 




endogenous messages are described in Appendix 6. Assays to determine mRNA 
steady-state abundances were performed as previously described (136).  Plasmids 
used in this study are listed in Appendix 2.  
 
Telomere Length Assays 
Genomic DNA was isolated from cells in mid-logarithmic using the “smash and 
grab” DNA preparation method (201). qPCR was used to determine yeast telomere 
repeat content (T) relative to the single-copy reference gene SGS1 (S) with the Bio-
Rad iTaq Universal SYBR Green. The T/S ratios were calculated from three 
experimental replicates at each of three DNA concentrations (100, 200, and 400 ng). 







Conclusion and Future Directions 
 
In Central Dogma of molecular biology, the mRNA ensures precise propagation of 
genetic information and functions as an effector of the cellular phenotype.  Post-
transcriptional regulation of mRNA quality and quantity governs the cellular 
homeostasis. Translational recoding, first described in viruses, has recently emerged 
as an important mechanism of post-transcriptional gene regulation (1)(3)(55). The 
focus of this thesis work has been to investigate the physiological relevance of 
translational recoding in human disease, with a primary focus on -1 PRF. Analysis of 
predicted -1 PRF signals across 20 genomes suggests that it is a universal mechanism 
(130). Thus the focus of this project has been to increase our knowledge of cellular 
gene regulation by -1 PRF.  
The involvement of -1 PRF in telomere maintenance is one of the major findings of 
this work.  How chromosome ends are stably maintained is one of the central 
questions of modern biology. Regulation of telomere length is also medically 
important because of its association with ageing and cancer. Proteins involved in 
yeast telomere maintenance are expressed in limited quantities and their defective 
expression leads to shorter telomeres (145). Operational -1 frameshift signals in 
messages involved in yeast telomere length maintenance are capable of affecting 
mRNA stability via NMD (186)(97). Here, we showed that rates of -1 PRF and the 




stoichiometries of these proteins. We found that global changes in the -1 PRF rates 
affects the abundances of these messages with attendant effects on stoichiometry and 
hence telomere length. In addition, these studies capitalized on the fact that the -1 
PRF signals in the telomere maintenance protein coding mRNAs   are operational 
along a wide range of -1 PRF efficiencies. We capitalized on these to define a 
mathematical relationship between -1 PRF efficiency and mRNA abundance as 
shown below (37). 
 
i.e. mRNA abundance is a function of -1 PRF efficiency ‘x’. The exponential 
relationship also suggests that there are limits to changes in -1 PRF above or below 
which effects may be seen. Another interesting observation is that the -1 PRF signals 
in these messages are not fully conserved in other yeasts (Appendix 6).  
 
In the course of this work, we also developed a novel qPCR based assay to analyze 
relative telomere length in yeast cells. This simple, rapid and scalable assay 
represents a significant improvement over conventional in-situ hybridization and 
Southern blot assays that had been the norm until now. Toward the end of this work 
we also began the process of expanding our studies of -1 PRF and telomere 
maintenance to human biology. Identification of functional -1 PRF signals in human 
telomere maintenance genes suggests that -1 PRF is widely used to control telomere 
length. Importantly, X-DC is characterized by progeria and telomere shortening.  
While the accepted dogma in this field is that mutations in XDC1 directly affect 




direct evidence supporting this.  Our findings suggest an alternative explanation for 
the telomere shortening and progeria phenotype of these patients.  Indeed, our 
findings in yeast and in human cells lead us to the hypothesis that global 
dysregulation of -1 PRF may contribute to disease pathogenesis. Here, we have used 
X-DC and SCA26 as model systems to understand other ribosomopathies, and to 
understand the normal aging process. Abnormalities in ribosome function that are 
implicated in both congenital and acquired syndromes have been broadly classified as 
‘ribosomopathies’. However, the precise molecular mechanisms that contribute to 
these pathologies are unknown. In Chapter 3, we used X-DC and SCA26 as model 
systems to investigate how mutations associated with the components of translational 
machinery affects gene expression. These mutations promote increased rates of -1 
PRF and increased fidelity at stop codons. These defects trigger enhanced rates of  
NMD-directed degradation on -1 PRF signal containing mRNAs. Preliminary data 
from our lab suggests that other pathologies associated with different ribosomopathies 
may also be due to specific defects in translational fidelity. We have found that the 
magnitude and type of translational fidelity defects can elicit enhanced NMD. 
However, the true contribution of dysregulation of -1 PRF and NMD to disease 
pathogenesis remains unknown. One avenue of future inquiry utilizes X-DC and 
SCA26 as the disease models to identify the repertoire of translationally regulated 
mRNAs associated with specific dysfunction in the translational apparatus. Such a 
course of inquiry would identify novel diagnostic and prognostic markers associated 





Sequence specific regulation of -1 PRF by ncRNAs as demonstrated with human 
CCR5 mRNA, the first in which -1 PRF is stimulated by miR-1224 (99), has 
potentially profound impact on our understanding of post-transcriptional gene 
regulation. Additionally an operational -1 PRF signal was also identified in the 
mRNA encoding human interleukin 2 receptor γ-chain (IL-2RG) encoding mRNA 
(Figure 29A). Defects in the expression of IL-2RG can result in Severe Combined 
Immunodeficiency Syndrome (SCID) (202). siRNA knockdowns of Argonaut 1 
(AGO1) stimulated IL-2RG mediated -1 PRF (Figure 29B). Additionally, single 
nucleotide polymorphisms (SNPs) identified within the IL-2RG -1 PRF sequence 
have the potential to alter -1 PRF efficiency, and thus may account for a SCID disease 
phenotype. This further broadens our hypothesis to include ‘dysregulation of miRNA 
expression as it affects -1 PRF may in part contribute to human disease phenotypes’.  
One possible way to identify miRNAs associated with cellular -1 PRF signals may be 
to perform in vivo pull-down experiments using specific -1 PRF signals as “bait”.   
 
Operational frameshift signals are also found in the genomes of alphaviruses: 
WEEV (Western equine encephalitis virus), EEEV (Eastern equine encephalitis 
virus) and VEEV (Venezuelan equine encephalitis virus) (203) . Alphaviruses 
belong to Togaviridae family and have +ssRNA genomes. The frameshift product is 
a structural component of the virion called TF (transframe). Alphaviruses are 
significant human pathogens and are classified as Category B select agents by the 
CDC based on a number of criteria including a history of being developed as 




Identification and characterization of regulation of PRF by miRNAs may suggest 











Figure 29. -1 PRF in human mRNA IL-2RG is regulated by miRNAs. 
(A) Predicted -1 PRF signal in human IL-2RG mRNA shown as Feynman diagram. Identified 
SNP is shown below the diagram. (B) -1 PRF efficiency was monitored using dual luciferase 
assay in cells transfected with mock, scrambled or AGO1 siRNA. Error bars denote standard 
error. 
 
The PRFdb predicted ~10% of the genes in humans have at least one functional -1 
PRF signal. This translates to 1,943 high probability -1 PRF signals in the human 
genome. We have cloned and validated -1 PRF signals in 13 human genes associated 
with different diseases. These are shown in Appendix 9 and their description is 





PRF signals need to be cloned and validated. In my postdoctoral work I will 
capitalize on the First-year Innovative and Research Experiences (FIRE) - Found in 
Translation (FIT) Research stream as a multiplier of labor and time. The FIRE-FIT 
research stream involves 30 undergraduate students that work in a laboratory setting 
to clone and validate predicted -1 PRF signals. Beginning this spring semester the 
students are being trained to clone and test selected human mRNA sequences. This 
will generate empirical for validating and identifying functional -1 PRF in the human 
genome. The list of -1 PRF sequences that are being cloned and tested are shown in 
appendix 11. We intend to follow up with questions regarding the biological and 
biomedical significance of -1 PRF.  
Next-generation sequencing of RNA and ribosome protected messages provide 
valuable information that can relate the observations of mRNA structure and function 
to individual molecules. The data generated using these techniques is increasing at an 
exponential rate. The genome wide predictions in PRFdb can be sieved through the 
available RNA-seq and ribosome profiling datasets to relate the individual predictions 
with mRNA abundance and ribosome pausing. Additionally the empirical data 
generated through the FIRE program will help us identify bonafide -1 PRF signals 
across the human genome. This will increase our understanding of how defects in the 









The HeLa and LCL cell lines were cultures as per the ATCC guidelines. HeLa 
cell lines were cultured at 37° with 5% CO2 using Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% irradiated fetal bovine serum (FBS), 1x 
non-essential amino acids (NEAA), 4 mM glutamine and 1% Penicillin/Streptomycin. 
The LCL cell lines (both normal and patient derived cells) were cultured in RPMI 
media supplemented with 10% FBS and 1% Penicillin/Streptomycin. The cells were 
passaged (HeLa cells using trypsin) when growing exponentially. The LCL cells were 
cultured in drug free RPMI medium for 6 hours post plasmid transfections.  
 
Dual Luciferase Assays 
Dual luciferase assays were performed using a Turner Biosystems GloMax-Multi 
Microplate Multimode Reader and Dual Luciferase Reagent Kit from Promega. Data 
analysis were performed as described in (156). 
Yeast cells were to mid-log phase before analysis. The cells were lysed using glass 
beads (instead of the recommended lysis buffer in the Promega kit) in PBS buffered 
lysis solution containing protease inhibitor cocktail. The lysates were diluted 1:2 – 
1:10 depending on the cell culture volume. The lysates were aliquoted in 96 well 
plates and analyzed in the luminometer using the 50 µl (as compared to suggested 




for the mammalian cells were performed as per the guidelines of the Promega 
protocol. 
 
Quantitative Real Time Reverse transcriptase PCR 
 
Yeast cells 
Yeast cells were grown to mid-log phase and RNA was isolated using Trizol Reagent 
with no modifications. DNAse digestion was done using the RNA Microaqueous kit 
from Ambion (Life Technologies). cDNA was made using the iScript cDNA 
synthesis kit from Bio-Rad. cDNA was diluted 1:100 – 1:10,000 depending the RNA 
concentration. Reactions were performed using the iTaq Universal SYBR green mix 
from Bio-Rad. Reactions were amplified using the Bio-Rad CFX 96 thermocycler as 
follows: 25⁰C for 10 seconds, 95⁰C for 5 min, followed by 45-60 cycles of 95⁰C for 
10 seconds, 48⁰C for 15 seconds, and 72⁰C for 15 seconds.  Melting curves were 
monitored by taking readings every 0.5⁰C from 55-95⁰C. U3 snoRNA was used as 
loading control. 
Mammalian cells 
RNA was isolated from mammalian cells using the Microaqueous kit from Ambion 
(Life Technologies).. cDNA was made using the iScript cDNA synthesis kit from 
Bio-Rad and diluted 1:10 – 1:100 depending the RNA concentration. Reactions were 
performed using the iTaq Universal SYBR green mix from Bio-Rad. Reactions were 
amplified using the Bio-Rad CFX 96 thermocycler as follows: 25⁰C for 10 seconds, 




seconds, and 72⁰C for 15 seconds.  Melting curves were monitored by taking readings 




Plasmid transfections were performed using modified FuGene HD transfection 
protocol from Promega. Efficient transfections were achieved using 3:1 ratio of 
plasmid to transfection reagent. The plasmid transfection reagent complexes prior 
adding to the cells were incubated in drug and serum free DMEM or RPMI media at 
room temperature. Transfections for LCL cells were performed using modified 
Nucleofector transfection kit V protocol from Lonza. Efficient transfection were 
achieved using double the amount pf plasmid as recommended in the protocol. Dual 
luciferase assays were performed 24-48 hours post transfections. 
siRNA 
Cells were transfected with synthetic RNA oligonucleotides specific to the mRNA of 
interest (hDKC1, hAGO1) or scrambled oligonucleotides using the HiPerFect 
transfection reagent from Qiagen.  Initial transfections were performed at 5, 10 and 
20 nM of siRNA for optimization.  Most final transfections were performed at 10 and 
20 nM. The siRNA-transfection reagent complexes were incubated in serum and drug 
free DMEM media prior adding to the cells. The media was replaced 6-8 hours after 
transfections. Assays were performed 12-24 hours post siRNA transfections.  When 
other plasmids were also transfected, the assays were performed 24-48 hours post 








Transformations using the bacterial strain DH5α were performed as described in 
(153) . For site-directed mutagenesis experiments (for larger plasmids and SDM 
products) a modified protocol as described in Quick Change Lightening Site-Directed 
mutagenesis was used. Stellar Competent cell (Clontech Laboratories Inc.) 
transformation protocol was used for DNA fragment assembly method used for -1 
PRF signal cloning. 
Yeast 
Yeast strains were transformed using modified alkali cation method as described in 
(205) . Yeast cells were grown in mid-log phase in YPAD or appropriate selective 
media. Transformations were performed using 0.1 M LiOAc/TE and excess (600 µl) 
PEG/LiOAc/TE buffers. Approximately double amount of ssDNA was used.  The 
sample were incubated at 30°C for 30-90 minutes (approximately double time 
recommended incubation time). The cells were heat shocked at 42°C for 15 minutes 
before plating on appropriate selective media. For the CBF5 strains the 












JD1361 yRP1674 MATa his3Δ leu2Δ met15Δ ura3Δ    Wild-type strain for 
steady state assays and 
frameshifting. 
JD1367  yRP2077 MATa upf1::KanMX4 his3Δ leu2Δ met15Δ 
ura3Δ 
NMD deficient strain 
isogenic to JD1361 for 
steady state. 
JD1228 MATα ura3-52 lys2-801 trp1Δ leu2Δ hisΔ 
RPL3::HIS3 pJD166_WT.trp 
Strain expressing wild-
type ribosomal protein L3 
on a plasmid(pJD166) for 
frameshifting and steady 
state assays 
JD1229 MATα ura3-52 lys2-801 trp1Δ leu2Δ his3Δ 
RPL3::HIS3 pJD166_mak8.trp 
Strain isogenic to JD1228 
expressing up-
frameshifting rpl3-
W255C/P257S (i.e. mak8) 
allele, for frameshifting 
and steady state assays 
JD1560 MATα ura3-52 lys2-801 trp1Δ leu2Δ his3Δ 
RPL3::HIS3 pJD166(R247A).trp 
Strain isogenic to JD1228 
expressing down-
frameshifting rpl3-R247A 
allele, for frameshifting 
and steady state assays 
JD1524 MATa  ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 
ura3-1 cbf5::TRP1 with CBF5 on pRS313 
Strain expressing wild-
type CBF5 gene  on a 
plasmid, for frameshifting 
and steady state assays 
JD1525 MATa ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 
ura3-1 cbf5::TRP1 D95A allele on pRS313 
Strain isogenic to JD1524 
expressing cbf5-D95A 
allele on a plasmid, for 
frameshifting and steady 
state assays 
JD960 MATa ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
can1-100 UPF1 UPF2 UPF3 
Wild-type strain for 
steady state assays. 
JD961 MATa ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
can1-100 upf1::HIS3 UPF2 UPF3 
NMD deficient strain 
isogenic to wild-type 
JD960 for steady states 
assays. 
JD967 MATa ade2-1 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
can1-100 upf1::LEU2 upf2::URA3 upf3::his3 
NMD deficient strain 
isogenic to wild-type 
JD960 for steady states 
assays. 
JD1263 MATa/α trp1Δ /trp1Δ leu2Δ/leu2Δ can1-100/can1-100 
ade2-1/ade2-1 est2Δ::URA3/EST2 upf2Δ::HIS3/UPF2 
VR-ADE2-TEL/VR-TEL (YJB2659) 
Parental diploi dstrain of 
est2 mutant strains used 




JD1281 MATa trp1Δ leu2Δ can1-100 ade2-1 ura3-1 his3-11 
VR-ADE2-TEL 
Wild-type strain for 
assaying telomere length 
JD1287 MATα trp1Δ leu2Δ can1-100 ade2-1 est2Δ::URA3 
his3-11 VR-ADE2-TEL 
Telomerase deficient 
strain to assay telomere 
length 
JD1288 MAT a trp1Δ leu2Δ can1-100 ade2-1 ura3-1 
upf2Δ::HIS3 VR-ADE2-TEL 
NMD deficient strain to 
assay telomere length 
JD1276 MAT a trp1Δ leu2Δ can1-100 ade2-1 est2Δ::URA3 
upf2Δ::HIS3 VR-ADE2-TEL 
Telomerase and NMD 
deficient strain to assay 
telomere length 
JD1693 MATα rpl10::KanMX lysΔ0 met15Δ leu2Δ ura3Δ 
his3Δ 
Strain expressing wild-
type ribosomal protein 
L10 on a plasmid for 
frameshifting and steady 
state assays 
JD1694 MATα rpl10-R98S::KanMX lysΔ met15Δ leu2Δ 
ura3Δ his3Δ 
Strain isogenic to JD1693 
expressing rpl10-R98S 
allele on a plasmid, for 
frameshifting and steady 
state assays 
JD1695 MATα rpl10::KanMX lysΔ met15Δ leu2Δ ura3 Δ 
NMD3Δ -Y379D his3Δ pURA3- NMD3Δ -Y379D 
Strain isogenic to JD1693 
expressing NMD3-Y379D 
allele on a plasmid, for 
frameshifting and steady 
state assays 
JD1696 MATα ade2 Δ lys2 Δ ura3 Δ his3 Δ leu2 Δ trp1 Δ 
eft1Δ:HIS3 eft2 Δ:TRP1 pURA3-EFT1 
Strain expressing wild-
type ribosomal protein 
eEF2 on a plasmid for 
frameshifting and steady 
state assays 
JD1697 MATα ade2 Δ lys2 Δ ura3 Δ his3 Δ leu2 Δ trp1 Δ 
eft1Δ:HIS3 eft2 Δ:TRP1 pURA3-eft1-P580H 
Strain isogenic to JD1696 
expressing eEF2-P580H 
allele on a plasmid, for 
frameshifting and steady 
state assays 
JD1698 MATα ade2 Δ lys2 Δ ura3 Δ his3 Δ leu2 Δ trp1 Δ 
eft1Δ:HIS3 eft2 Δ:TRP1 pURA3- eft1-H699Q 
Strain isogenic to JD1696 
expressing eEF2-H699Q 
allele on a plasmid, for 
frameshifting and steady 
state assays 




Appendix 2: Yeast based plasmids  
 
Plasmid Name Backbone 
Plasmid 
Description 
pJD375 pRS316 Dual luciferase cassette in pRS316, genomic context  
pJD376 pJD375 LA frameshift signal sequence inserted in dual luciferase 
reporter, viral context  
pJD521 pJD375 EST2 PRF sequence  at 1653 inserted in dual luciferase 
reporter, viral context  
pJD1017 pJD375 EST2 PRF sequence  at 72 inserted in dual luciferase 
reporter, viral context 
pJD1018 pJD375 EST2 PRF sequence  at 1215 inserted in dual luciferase 
reporter, viral context 
pJD1019 pJD375 EST2 PRF sequence  at 1326 inserted in dual luciferase 
reporter, viral context 
pJD1020 pJD375 EST2 PRF sequence  at 1920 inserted in dual luciferase 
reporter, viral context 
pJD1038 pJD375 STN1 PRF sequence  at 885 inserted in dual luciferase 
reporter, viral context 
pJD1039 pJD375 STN1 PRF sequence  at 1203 inserted in dual luciferase 
reporter, viral context 
pJD1040 pJD375 EST1 PRF sequence  at 885 inserted in dual luciferase 
reporter, viral context 
pJD1042 pJD375 EST1 PRF sequence  at 1272 inserted in dual luciferase 
reporter, viral context 
pJD1043 pJD375 EST1 PRF sequence  at 1920 inserted in dual luciferase 
reporter, viral context 
pJD1803 pJD375 CDC13 PRF sequence  at 1272 inserted in dual luciferase 
reporter, viral context 
pJD753 pJD0741 Readthrough containing small amounts of Renilla and 
Firefly in PGK1 reporter  
pJD828 pJD753 Premature termination codon in PGK1 reporter  
pJD754 pJD753 EST2 PRF sequence at 1653 inserted in PGK1 reporter  
pJD766 pJD753 EST2 PRF sequence at 1215 inserted in PGK1 reporter 
pJD1071 pJD753 EST2 PRF sequence at 1326 inserted in PGK1 reporter 
pJD1074 pJD753 STN1 PRF sequence at 1203 inserted in PGK1 reporter 
pJD1076 pJD753 EST1 PRF sequence at 1272 inserted in PGK1 reporter 
pJD1804 pJD753 CDC13PRF sequence at 1272 inserted in PGK1 reporter 
pJD0808 pJD521 EST2 PRF sequence at 1653inserted in dual luciferase 
reporter, viral context, mutated slip site  
pJD1805 pJD1018 EST2 PRF sequence at 1215 inserted in dual luciferase 
reporter, viral context, mutated slip site  
pJD1806 pJD1019 EST2 PRF sequence at 1326 inserted in dual luciferase 
reporter, viral context, mutated slip site  
pJD1807 pJD1039 STN1 PRF sequence at 1203 inserted in dual luciferase 
reporter, viral context, mutated slip site  
pJD1808 pJD1041 EST1 PRF sequence at 1272 inserted in dual luciferase 
reporter, viral context, mutated slip site  




reporter, viral context, mutated slip site  
pJD641 pJD638 Full length EST2 low copy plasmid  
pJD796 pJD641 Mutated full length EST2 low copy plasmid  
pJD972(T7) pTNT Yeast telomeric sequence under T7 promoter control 
pJD972(M13) pBC6 Yeast telomeric sequence flanked by M13 
pJD985 pJD641 Full length EST2 low copy plasmid with mutations to the 
positions 72,1215,1326,1653 PRF sequence  
pJD1048 pRS313 CBF5 wild-type in pRS313 (a,l) 
pJD1049 pRS313 CBF5 D95A in pRS313 (a,l) 
 






Appendix 3: Mammalian plasmids 
 
Plasmid Name Backbone 
Plasmid 
Description 
pJD0175f P2luci (206) pJD175f is identical to p2luci 
pJD0187 P2luci Insertion of the HIV-1 PRF signal into the dual luciferase 
plasmid 
pJD0827 pJD175e Insertion of the CCR5 PRF signal into the dual luciferase 
plasmid  
pJD0835 pJD175e Insertion of the homo sapiens IL7α PRF signal into the dual 
luciferase plasmid  
pJD1525 pJD175f Dual luciferase vector with an in-frame UAA codon after 
Renilla. 
pJD1526 pJD175f Dual luciferase vector with an in-frame UAG codon after 
Renilla. 
pJD1527 pJD175f Dual luciferase vector with an in-frame UGA codon after 
Renilla. 
pJD1800 pJD175f Insertion of the IL2Rγ PRF signal into the dual luciferase 
plasmid 
pJD1529 pJD175f Insertion of the eIF2B3 PRF signal into the dual luciferase 
plasmid 
pJD1530 pJD175f Insertion of the RASA4 PRF signal into the dual luciferase 
plasmid 
pJD1532 pJD175f Insertion of the PARP1 PRF signal into the dual luciferase 
plasmid 
pJD1533 pJD175f Insertion of theTERF2 PRF signal into the dual luciferase 
plasmid 
pJD1534 pJD175f Insertion of the TERF2IP PRF signal into the dual 
luciferase plasmid 
pJD1535 pJD175f Insertion of the SMG6 PRF signal into the dual luciferase 
plasmid 
pJD1536 pJD175f Insertion of the IPO11 PRF signal into the dual luciferase 
plasmid 
pJD1537 pJD175f Insertion of the eIF5B PRF signal into the dual luciferase 
plasmid 
pJD1538 pJD175f Insertion of the ATG7 PRF signal into the dual luciferase 
plasmid 
pJD1539 pJD175f Insertion of the SelL PRF signal into the dual luciferase 
plasmid 
pJD1540 pJD175f Insertion of the COL8A1 PRF signal into the dual luciferase 
plasmid 
pJD1541 pJD175f Insertion of the RBBP4 PRF signal into the dual luciferase 
plasmid 
pJD1542 pJD175f Insertion of the MTAP PRF signal into the dual luciferase 
plasmid 





pJD1544 pJD175f Insertion of the PKHD1 PRF signal into the dual luciferase 
plasmid 
pJD1545 pJD175f Insertion of the PDCD7 PRF signal into the dual luciferase 
plasmid 
pJD1546 pJD175f Insertion of the ARRB1 PRF signal into the dual luciferase 
plasmid 























Appendix 4: Oligonucleotides for Cloning 
 
Oligo name Clone Sequence 
YLR318W, 









EST2 PRF1 pJD659 5’CCCATTTTCGTTCTTCAGGGCATCCTTGAG3’ 
EST2 PRF2 pJD660 5’GATACTTGGAATAAACTTATCACTCCATTCATCGT
AGAATATTTTAAGACG3’ 
EST2 PRF3 pJD661 5’GCAAAATGAGGATTATACCTAAGAAGAGTAATAA
TGAGTTCAGG3’ 
EST2 PRF4 pJD662 5’GAGGATACTCAAGGATGCGCTGAAGAACGAAAAT
GGG3’ 
EST2 PRF5 pJD667 5’GCCAGTCCTAGCCAGGACACATTAATATTGAAGCT
GGCTGACGATTTCC3’ 







































































































































Appendix 5: Oligonucleotides for Site-Directed Mutagenesis 












































































































Appendix 6: Oligonucleotides used for qPCR. 
Name Template Sequence 
yEST2 
qPCR Fwd 
Yeast cDNA 5’TGGTCGGTACATACGCATTC3’ 
yEST2 
qPCR Rev 
Yeast cDNA 5’CGGCAGATGAGGTTCGTTAC3’ 
yEST1 
qPCR Fwd 
Yeast cDNA 5’ATTCCGTGATACCATTGGTTC3’ 
yEST1 
qPCR Rev 
Yeast cDNA 5’CTTTCTTCTGTTACTTAGTCGCA3’ 
ySTN1 
qPCR Fwd 
Yeast cDNA 5’ACAGCAAATACACCTTATTGGC3’ 
ySTN1 
qPCR Rev 
Yeast cDNA 5’ACCAATGAAGAGTCTGAAGTACA3’ 
yCDC13 
qPCR Fwd 
Yeast cDNA 5’TGGTAAGTGTGATAAGCACC3’ 
yCDC13 
qPCR Rev 













U3 Forward Yeast cDNA 5’TCCAACTTGGTTGATGAGTCC3’ 
U3 Reverse Yeast cDNA 5’CGAACCGCTAAGGATTGC3’ 
yCCR4 
qPCR Fwd 












Yeast cDNA 5’ GGG TAAGAATGAAGTTGTCGAGACTTC 3’ 
 
yTel Fwd Yeast gDNA 5’CAGTGGTGTGGGTGTGCATGGTGGTGTGGGTGTGT
GG  3’ 
 

















































Appendix 7: Phylogenetic analysis of predicted -1 PRF signals in 
ORFs involved in yeast telomere maintenance  
 





































































































































                  
 
 













































































































































































































                   
 



























































Table 10. Phylogenetic analysis of predicted -1 PRF signals in ORFs involved in yeast 
telomere maintenance. 
The orthologs of EST1, STN1 and CDC13 from Saccharomyces cerevisiae, S. paradoxus, S. 
mikatae, S. bayanus, S. castellii, S. kudriavzevii and S. kluyveri were queried for -1 PRF 
signals. The information in this table includes each slippery site, its location, predicted 
downstream mRNA pseudoknot secondary structures and their predicted Minimum Free 
Energies (MFE) as obtained from PRFdb (http://prfdb.umd.edu/). The sequences were 
queried for the potential – 1 PRF signals as described in [1]. Similar analysis for EST2 is 
described in[2]. Slippery site locations are hyperlinked to URLs for all potential folding 

















Appendix 8: RNAi Oligonucleotides 
 
Table 11. RNAi oligonucleotides used in this study. 
The siRNA oligonucleotides include both sense and anti-sense RNA strands with two 




Target: 5’ TA GTC TTA ACA TAA AGC CGA A    3’ 
Sense:  5’    GUC UUA ACA UAA AGC CGA Att  3’ 
Anti:   3’ at CAG AAU UGU AUU UCG GCU U    5’ 
hRENT1 
(UPF1) 
Target: 5’ CA CCA TGA GCG TGG AGG CGT A    3’ 
Sense:  5’    CCA UGA GCG UGG AGG CGU Att  3’ 
Anti:   3’ gt GGU ACU CGC ACC UCC GCA U    5’ 
Scrambled Target: 5’ AAT TCT CCG AAC GTG TCA CGT     3’ 
Sense:  5’ UUC UCC GAA CGU GUC ACG Utt     3’  















% -1 PRF 
(+error) 
pJD1536 IPO11 Importin 11 898 2.46%  + 0.14% 
pJD1538 ATG7 Autophagy related 7 80 10.45%  + .42% 




Collagen, type VIII, alpha 1 
 
1710 








pJD1542 MTAP Methylthioadenosine 
Phosphorylase 
245 0.63% +0.03% 
















pJD1529 eIF2B3 eukaryotic translation initiation 
factor 2B, subunit 3 gamma 
541 2.34% +0.41% 
pJD1530 RASA2 RAS p21 protein Activator 4 
 
3024 1.41% +0.11% 
pJD1532 PARP1 poly (ADP-ribose) polymerase 
family, member 1 
654 1.48% +0.33% 
pJD1546 ARRB1 arrestin, beta 1, transcript 
variant 1, mRNA 
143 4.19% +0.85% 
 
Table 12. Additional validated -1 PRF signals in Humans. 
Computationally identified putative -1 PRF signals were cloned in the dual luciferase 
reporter and -1 PRF efficiencies were assayed in HeLa cells. These frameshift signals 
were cloned by undergraduate students Tyler Thrasher, Yousuf Khan, Kristen Langan, 





Appendix 10: Summary of the additional validated -1 PRF signals in 
Humans 
 
Importin 11 (IPO11) – It belongs to the karyopherin/importin-beta family 
that are receptors involved in nucleocytoplasmic transport (207). It functions 
by docking the importin/substrate complex to the nuclear pore complex (NPC) 
and transports is achieved   by Ran-dependent mechanism (208). It is involved 
in transport of large subunit (LSU) ribosomal protein L12. 
Autophagy related (factor) 7 (ATG7) - E1-like activating enzyme required 
for cytoplasm to vacuole transport and autophagy (209). Association of ATG7 
with ATG12 (Autophagy related (factor) 12) activates the ATG8 family 
proteins required for autophagy by inhibition of caspase-8 (210)(211). 
Selectin L (SELL) – It belongs to the family of adhesion/homing receptors 
(212). The protein has C-type lectin-like and calcium-binding epidermal 
growth factor-like domains (213)(214) . It facilitates the adhesion of 
leucocytes on endothelial cells. A SNP in the SELL gene is associated with 
immunoglobulin A nephropathy (215). 
Collagen, Type VIII, Alpha (COL8A) - It’s a major component of the sub 
endothelial Descemet's membrane and endothelia of blood vessels (216). It is 
involved in the smooth muscle cell migration and proliferation, thus playing 
an important role atherogenesis (216). Diseases associated with COL8A 





Retinoblastoma Binding Protein 4 (RBBP4) – It is a component of many 
complexes that include chromatin assembly factor 1 (CAF-1) complex, the 
histone deacetylase (HDAC) complex, the nucleosome remodeling and 
histone deacetylase (NuRD) complex (219)(220) . All these complexes are 
important for chromatin homeostasis. Diseases associated with RBBP4 
include retinoblastoma and intermediate charcot-marie-tooth neuropathy 
(221)(222)(223). 
 Methylthioadenosine Phosphorylase (MTAP) – It is involved in the 
breakdown of catalyzes the phosphorylation of S-methyl-5'-thioadenosine 
(MTA) by catalyzing the phosphorylation of MTA to adenine and 5-
methylthioribose-1-phosphate (224). MTA is a major by product polyamine 
biosynthesis. Diseases associated with MTAP include diaphyseal medullary 
stenosis with malignant fibrous histiocytoma, and acute lymphoblastic 
leukemia (225)(226)(227).  
Ret Proto-Oncogene (RET) – It is a member of the cadherin superfamily and 
encodes for receptor tyrosine kinase involved in cell migration, proliferation 
and differentiation (228). It also plays a major role in neuronal 
navigation(228). Diseases associated with RET include familial papillary 
thyroid carcinoma, Central hypoventilation syndrome, congenital, renal 
agenesis and lichen amyloidosis (229)(230). 
Polycystic Kidney And Hepatic Disease 1 (PKHD1) – It is a transmembrane 




in PKHD1 result in autosomal recessive polycystic kidney disease, also 
known as polycystic kidney and hepatic disease-1 (233). 
Programmed Cell Death 7 (PDCD7) – It is a component of the U12 
spliceosome complex and overexpression leads to cell apoptosis(234)(235). 
Its expression is selectively regulated during the apoptosis of T-cell thymoma 
cells (236). 
Eukaryotic translation initiation factor 2B, subunit 3 gamma (eIF2B3) - It 
is one of the subunits of eukaryotic initiation factor 2B which catalyzes the 
exchange of eukaryotic initiation factor 2-bound GDP for GTP (237).Diseases 
associated with EIF2B3 include eif2b3-related childhood ataxia with central 
nervous system hypomyelination/vanishing white matter and childhood ataxia 
with central nervous system hypomyelination/vanishing white matter 
(238)(239). 
RAS p21 Protein Activator 2 (RASA2) – It belongs to the family of the 
GTP-ase activating proteins and it stimulates the GTPase activity if the RAS 
p21 acting as a suppressor of the RAS function(240)(241). RASA2 is 
associated neurofibromatosis (242).  
Poly (ADP-ribose) polymerase family, member 1 (PARP1) – It is involved 
in the poly-ADP-ribosylation of multiple nuclear proteins. It plays an 
important role in cell division, proliferation, DNA damage repair and tumor 





Arrestin Beta 1 (ARRB1) – It’s a member of the beta-arrestin protein family 
and involved in the agonist-mediated desensitization of G-protein-coupled 
receptors (246)(247). Recently it has been identified as a cofactor in the beta-
adrenergic receptor kinase (BARK) mediated desensitization of beta-
adrenergic receptors.  













Appendix 11: Human -1 PRF being cloned by the FIRE class 
 
ORF Gene annotation Position  Slippery site 
 eIF4G eukaryotic translation initiation factor 4 gamma 3806 GGGAAAA 
 eIF4G eukaryotic translation initiation factor 4 gamma 1347 CCCUUUG 
eIF5B eukaryotic translation initiation factor 5B 3637 AAAAAAA 
eIF5B eukaryotic translation initiation factor 5B 2242 AAAUUUU 
eIF4B eukaryotic translation initiation factor 4B 1811 CCCAAAA 
EIF3E eukaryotic translation initiation factor 3 E 480 UUUUUUU 
EIF2AK4 eukaryotic translation initiation factor 2 alpha 
kinase 4 
326 AAAAAAU 
CHST14 carbohydrate (N-acetylgalactosamine 4-0) 
sulfotransferase 14 
233 CCCAAAU 
EBF1 early B-cell factor 1 908 GGGAAAC 
PDZD2 PDZ domain containing 2 
 
6880 GGGAAAA 
PTPN11 Homo sapiens protein tyrosine phosphatase, 
non-receptor type 11 (Noonan syndrome 1) 
227 CCCAAAU 
WASL Wiskott-Aldrich syndrome-like 1544 AAAAAAA 
ZFHX3 Zinc finger homeobox protein 3 5694 CCCUUUC 
 
MAP4K3 mitogen-activated protein kinase kinase kinase 
kinase 3 
527 CCCAAAU 
MAP4K3 mitogen-activated protein kinase kinase kinase 
kinase 3 
2459 CCCUUUA 




kinase 5  
E1F1A eukaryotic translation initiation factor 1A 406 AAAAAAG 
RASIP1 Pas interacting protein 1 2235 CCCUUUC 
BCL9 B-cell CLL/lymphoma 9 2603 CCCAAAC 
BCL9 B-cell CLL/lymphoma 9 2549 AAAUUUU 
BCL9 B-cell CLL/lymphoma 9 4247 GGGUUUC 
CDH16 cadherin 16 928 GGGAAAC 
CDH16 cadherin 16 178 AAAUUUC 
ABL1 tyrosine-protein kinase ABL1 951 CCCAAAG 
CDH13 cadherin-13 477 GGGAAAC 
BAG3 BCL2-associated athanogene 3 1259 CCCAAAA 
BAG3 BCL2-associated athanogene 3 338 CCCUUUC 
BCL2L11 BCL2-like 11 483 CCCUUUU 
GATA5 GATA binding protein 5 341 CCCUUUC 
FOXJ2 forkhead box J2 2129 GGGAAAG 
FOXI3 forkhead box I3 1152 CCCUUUC 
FOXL1 forkhead box L1 1019 GGGAAAG 
BMP5 bone morphogenetic protein 5 748 GGGUUUC 
GPR31 G protein-coupled receptor 31 9 CCCAAAC 
AEN interferon stimulated exonuclease gene 20kDa-
like 1 
740 CCCAAAC 
SLC52A1 G protein-coupled receptor 172B 844 GGGAAAC 
GRK 4 G protein-coupled receptor kinase 4 1847 CCCUUUC 
Table 13. Additional -1 PRF signals being cloned by the FIRE class. 
Computationally identified potential -1 PRF signals mentioned in the table above are 
being cloned in the dual luciferase reporter by the First-Year Innovative and Research 
Experience (FIRE) stream – Found in Translation (FIT). -1 PRF efficiencies of the 
successful cloned sequences assayed in HeLa cells by dual luciferase assays during the 
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